Document:

CAMBEX CORPORATION

                   360 Second Avenue
             Waltham, Massachusetts  02451

                                                November 12, 1999

Mr. Joseph F. Kruy
21 Driftwood Lane
Weston, Massachusetts  02493

Dear Joe:

     This letter is to confirm the arrangements agreed
to between you and Cambex Corporation (the "Company")
relating to your continued employment by the Company.

     1.   Term of Employment.  The Company agrees that
it will employ you, and you agree to serve, under the
terms of this agreement from the date hereof until
December 31, 2002 unless earlier terminated pursuant
hereto.

     2.   Full Time Employment.  You are presently
Chairman of the Board of Directors and the President
and Chief Executive Officer of the Company.  You agree
to continue to diligently perform the duties, and
assume the responsibilities, of those officers and such
additional executive and managerial duties and
responsibilities (as are consistent with the functions
normally performed by a chief executive officer) as
shall from time to time be assigned to you by the Board
of Directors.  Except for illness and reasonable
vacations, during the term of this Agreement Period you
shall devote all of your working time and attention and
your best efforts to the performance of your duties and
responsibilities hereunder, provided that nothing
herein contained shall be deemed to prevent or limit
your right (i) to invest in the securities of any
corporation whose securities are publicly owned if your
ownership of such securities shall be less than 1% of
the issued and outstanding securities of any such
corporation, (ii) to make any other passive investments
where you are not obligated to or required to, and
shall not in fact, devote any managerial efforts, (iii)
to participate in charitable, community or educational
activities, (iv) to participate in trade or
professional organizations or (v) subject to the
approval of the Board of Directors (which approval
shall not be unreasonably withheld or withdrawn), to
hold directorships in public companies, except only
that the Board of Directors shall have the right to
limit such activities whenever it reasonably believes
that the time spent on such activities infringes upon
the time required by you for performance of your duties
hereunder.  You agree to enter into the Employee
Agreement relating to inventions and noncompetition to
which all other executive and professional employees of
the Company are parties.

     3.   Compensation.

          (a)  Fixed Compensation.  As fixed
     compensation for services rendered hereunder, the
     Company agrees to pay your minimum base
     compensation at the rate of $200,000.00 per year,
     payable according to the Company's regular pay
     practices, which amount may be increased from time
     to time by the Board of Directors in its sole
     discretion.

          (b)  Incentive Bonus.  In addition to the
     fixed compensation provided in subparagraph (a),
     the Company agrees that pursuant to the Company's
     Incentive Bonus Plan, as it may be amended from
     time to time (the "Plan"), you will receive an
     incentive bonus in an amount equal to four percent
     of the Company's pretax profit as defined in that
     Plan for each fiscal year during the term of this
     Agreement.

     4.   Termination of Employment.  If your
employment should terminate prior to December 31, 2002,
the following provisions shall govern and you shall not
be entitled to any compensation for any reason except
as follows:

          (a)  Voluntary Termination or Termination for
     Cause.  If you voluntarily terminate your
     employment or the Company terminates your
     employment for cause, you shall be entitled to
     receive only your fixed compensation provided in
     paragraph 4(a) to and until the date of
     termination of your employment plus such portion
     of your incentive bonus to which you are entitled
     on such date under the Plan.

          (b)  Termination by the Company other than
     for Cause.  If your employment is terminated by a
     majority of the Board of Directors of the Company
     other than for cause, you will be entitled to
     receive fixed compensation at the then current
     rate pursuant to paragraph 4(a) until and
     including December 31, 2002.  In addition, you
     shall be entitled to receive any incentive bonus
     earned under the Plan during the fiscal year in
     which your employment is terminated in the full
     amount which you had been awarded under Par. 3(b)
     and to be awarded the right to earn incentive
     bonuses of one-half such amount under the Plan
     (but not less than two percent of the Company's
     pretax profits as defined in the Plan) during each
     fiscal year thereafter through December 31, 2002.

          (c)  Termination by the Company of your
     Status as Chief Executive Officer.  If a majority
     of the Board of Directors of the Company, without
     your consent, should designate an person other
     than you as the Chief Executive Officer of the
     Company (either directly by conferring that title
     on another person or indirectly by conferring the
     powers of the Chief Executive Officer to another
     person), you will be entitled to resign and to
     treat that action by the Company as a termination
     of your employment other than for cause.

          (d)  Mitigation of Damages:  Noncompetition.
     If you should accept employment elsewhere than at
     the Company during the period following
     termination of your employment and prior to
     December 31, 2002, the Company shall be entitled
     to a credit against amounts otherwise payable to
     you hereunder for the period after January 1, 2001
     in the amount of compensation paid to you from
     such other employment after January 1, 2001.

          If you should accept employment from any
     entity which is directly and significantly in
     competition with the Company during such period of
     time, the Company's obligation to make payments to
     you, other than payments described in subparagraph
     4(a), shall cease.

          (e)  Limitation on Right to Damages.
     Notwithstanding the foregoing, you shall not be
     entitled to receive any amounts for any period
     subsequent to termination of your employment if

               (i)  On the effective date of such
                    termination, the assets of the
                    Company are in the hands of a
                    receiver, assignee for the benefit
                    of creditors, trustee in
                    bankruptcy, debtor in possession,
                    or other entity for the benefit of
                    creditors; or

               (ii) The consolidated net worth of the
                    Company on the effective date of
                    termination is less than the
                    consolidated net worth of the
                    Company shown on the Company's
                    December 31, 1999 balance sheet.

     5.   Definition of "Cause".  For purposes of this
agreement, the term "cause" shall mean the following:

          (a)  Your continuing any arrangement or
     holding any position which conflicts with the
     interest of or which interferes with your duties
     owed to the Company for more than thirty days
     after written notice by the Company to you
     thereof;

          (b)  Your conviction of a felony;

          (c)  Your deliberate misappropriation of
     corporate funds;

          (d)  Your refusal to perform assigned duties
     where such assignment is consistent with your
     engagement hereunder as an executive officer of
     the Company and is not a basis for your treating
     the Company's action as a termination of your
     employment pursuant to subparagraph 4(c).

     If the Company asserts that it has cause for your
discharge under subparagraph (d) above, the Company
will give thirty days' written notice to you specifying
the action or inaction on your part which is the basis
of the asserted right to terminate and advising you
that it is the Company's intention to terminate your
employment.  Your employment will terminate in
accordance with such notice unless within such period
of thirty days you shall remedy the cause in respect of
which such notice was sent.  If during such thirty-day
period you notify the Company that you dispute the
grounds for discharge or dispute the assertion that
admitted action or inaction constitutes a basis for
discharge, the dispute shall be submitted to
arbitration in the following manner:

     You shall give written notice to the Company
naming an arbitrator and requesting that the Company
name an arbitrator within ten days.  The two
arbitrators thus selected shall select a third, and a
decision of any two of the three shall be binding upon
the parties.  Should the Company fail to appoint an
arbitrator within the ten-day period mentioned above,
the arbitrator appointed by you will act as sole
arbitrator.  If the two arbitrators shall be unable to
agree upon a third arbitrator within a period of ten
days after the appointment of the Company's arbitrator,
the selection of an additional arbitrator shall be made
by the American Arbitration Association in Boston,
Massachusetts.  The decision of any two of the three
arbitrators shall be binding upon the parties and said
decision shall be reduced to a judgment in any court
having jurisdiction.  The arbitrators will be
instructed to conduct their arbitration informally and
expeditiously, the arbitration to be completed in all
events within thirty days after the appointment of the
third arbitrator (or within thirty days after the
Company has failed to appoint its arbitrator, as the
case may be).  Failure of either party to cooperate
with the arbitrators will be a basis for the
arbitrators to make a finding against the non-
cooperating party.  Each party shall bear his or its
own expenses in connection with such an arbitration
except that the expenses of the arbitrators themselves
shall be borne in accordance with their award.  All
matters respecting your employment shall remain in
status quo pending the outcome of any dispute which is
submitted to arbitration hereunder, and the parties
shall, during such arbitration, proceed with the
performance of their respective obligations hereunder
until final determination is made.  If the award of the
arbitrators is unfavorable to you, you shall
nevertheless have a reasonable period, to be set by
them, following the rendering of their award within
which to conform to the Company's assignment of duties
to you, thereby restoring you to good standing under
this Agreement.

     6.   Merger, etc.  This agreement shall be binding
upon any successor to the Company in the event that the
Company consolidates with any other entity or in the
event that the Company is a party to a merger where the
Company is not the surviving entity.  This agreement
shall be binding upon and inure to the benefit of the
Company and its successors and assigns and you and your
heirs, executors and administrators.

     7.   Notices.  All notices required to be given
hereunder shall be in writing and shall be considered
duly given on two days after the date of deposit in the
mail, return receipt requested, if mailed to the
address listed below or such other addresses as may be
given by either party to the other by notice hereunder:

     If you:   At your address shown in the inside
address at the beginning of this letter;

     If to the
     Company:  Its address as it appears on the
               letterhead appearing on the first page
               of this agreement.

     8.   Massachusetts Law.  This Agreement shall be
governed by and construed in accordance with the laws
of The Commonwealth of Massachusetts.

     9.   Waivers.  Waiver by the Company of any breach
of any provision of this Agreement by you shall not
operate or be construed as a waiver of any subsequent
breach by you.

     10.  Entire Agreement.  This instrument contains
the entire agreement of the parties.  This Agreement
shall be modified or terminated only by a writing
signed by you and the Company.

     If you accept and agree to the foregoing, please
so signify by signing and returning a counterpart of
this letter, whereupon this letter will become an
agreement between you and the Company as of the date
first above written.

                                   Very truly yours,
                                   CAMBEX CORPORATION

                                   By: /s/ Philip C. Hankins
                                         Philip C. Hankins

Accepted and agreed to:

/s/ Joseph F. Kruy
    Joseph F. KruySERIES 1 BRIDGE NOTE PURCHASE AGREEMENT

                         among

                  CAMBEX CORPORATION
                    (the "Company")

                          and

   The Persons Listed On The Signature Pages Hereto
                  (the "Purchasers")

             Dated as of January 18, 2000

This Series 1 Bridge Note Purchase Agreement provides
for the offer, sale, issuance, and delivery of up to
$2,000,000 in principal amount of Convertible Series 1
Bridge Financing Notes with attached Repricing Warrants
and accompanying Purchaser Warrants.

                   TABLE OF CONTENTS

SECTION 1.     BRIDGE NOTES.                                   2
     Section 1.1     Authorization, Issuance, and Sale of Notes. 2
     Section 1.2         Authorization and Issuance of Warrants. 2
     Section 1.3                                Form of Payment. 2
     Section 1.4                                        Closing. 3
     Section 1.5                          Deliveries at Closing. 3
     Section 1.6            Deliveries by Guarantors at Closing. 3
SECTION 2.     PLEDGED SHARES; APPOINTMENT OF
     REPRESENTATIVE.                                           4
     Section 2.1                                 Pledged Shares. 4
     Section 2.2        Appointment of Purchaser Representative. 4
     Section 2.3                                     Assurances. 5
     Section 2.4            Default and Acceleration Procedures. 5
     Section 2.5         Standard of Care of the Representative. 6
SECTION 3.     REPRESENTATIONS AND WARRANTIES OF
     THE COMPANY.                                              7
     Section 3.1                 Organization and Qualification. 7
     Section 3.2Authorization, Enforcement, Compliance with Other Instruments.7
     Section 3.3                                 Capitalization. 9
     Section 3.4                         Issuance of Securities. 9
     Section 3.5                                   No Conflicts. 9
     Section 3.6           SEC Documents;  Financial Statements. 10
     Section 3.7                     Absence of Certain Changes. 11
     Section 3.8                          Absence of Litigation. 11
     Section 3.9                         Purchase of Securities. 11
     Section 3.10No Undisclosed Events, Liabilities, Developments, or
                 Circumstances.                                  11
     Section 3.11                       No General Solicitation. 11
     Section 3.12                        No Integrated Offering. 11
     Section 3.13                            Employee Relations. 12
     Section 3.14                  Intellectual Property Rights. 12
     Section 3.15                            Environmental Laws. 12
     Section 3.16                                         Title. 12
     Section 3.17                                     Insurance. 13
     Section 3.18                            Regulatory Permits. 13
     Section 3.19                  Internal Accounting Controls. 13
     Section 3.20          No Materially Adverse Contracts, Etc. 13
     Section 3.21                                    Tax Status. 13
     Section 3.22                          Certain Transactions. 14
     Section 3.23                               Dilutive Effect. 14
     Section 3.24              Fees and Rights of First Refusal. 14
     Section 3.25                 Foreign Corrupt Practices Act. 14
     Section 3.26                                    Disclosure. 14
SECTION 4. REPRESENTATIONS AND WARRANTIES OF THE
     GUARANTORS.                                              15
     Section 4.1                 Organization and Qualification. 15
     Section 4.2Authorization, Enforcement, Compliance with Other Instruments.15
SECTION 5.  REPRESENTATIONS, WARRANTIES, AND
     COVENANTS OF PURCHASERS                                  15
     Section 5.1                             Investment Purpose. 16
     Section 5.2                     Accredited Investor Status. 16
     Section 5.3                         Reliance on Exemptions. 16
     Section 5.4                                    Information. 16
     Section 5.5                         No Governmental Review. 16
     Section 5.6                             Transfer or Resale. 16
     Section 5.7                                        Legends. 17
     Section 5.8                      Authorization Enforcement. 17
     Section 5.9                                      Residence. 17
     Section 5.10               No Scheme to Evade Registration. 17
     Section 5.11                         Covenant Not to Trade. 18
SECTION 6.  CONDITIONS OF INITIAL CLOSING                     18
     Section 6.1                         Transaction Agreements. 18
     Section 6.2                             Opinion of Counsel. 18
     Section 6.3     Representations and Warranties; No Default. 19
     Section 6.4           Delivery of Schedules; Due Diligence. 19
     Section 6.5 Purchase and Loan Permitted by Applicable Laws. 19
     Section 6.6                          No Adverse Litigation. 19
     Section 6.7                         Approvals and Consents. 19
     Section 6.8                     No Material Adverse Change. 19
     Section 6.9                                    Proceedings. 19
     Section 6.10                             Clerk Certificate. 20
     Section 6.11                   Transfer Agent Instructions. 20
SECTION 7.  CONDITIONS TO SUBSEQUENT CLOSINGS                 20
     Section 7.1     Representations and Warranties; No Default. 20
     Section 7.2                                 No Suspensions. 20
     Section 7.3                             Opinion of Counsel. 20
     Section 7.4                                  Due Diligence. 21
     Section 7.5                           Shareholder Approval. 21
     Section 7.6                     No Material Adverse Change. 21
SECTION 8.  AFFIRMATIVE COVENANTS                             21
     Section 8.1                          Financial Information. 21
     Section 8.2                                         Form D. 22
     Section 8.3                               Reporting Status. 22
     Section 8.4                         Inspection of Property. 22
     Section 8.5           Maintenance of Properties; Insurance. 22
     Section 8.6                                       Reserved. 22
     Section 8.7                                       Expenses. 22
     Section 8.8Authorized Shares of Common Stock, Reservation of Shares.  23
     Section 8.9                       Corporate Existence, Etc. 23
     Section 8.10                               Transfer Agents. 23
     Section 8.11                   Shareholder Approval; Proxy. 23
     Section 8.12                   Transfer Agent Instructions. 23
     Section 8.13                              Payment of Taxes. 24
     Section 8.14                     Compliance with Laws, Etc. 24
     Section 8.15                               Use of Proceeds. 24
     Section 8.16                        Registration Statement. 24
     Section 8.17                                      Listings. 25
     Section 8.18                               Indemnification. 25
SECTION 9. NEGATIVE COVENANTS                                 25
     Section 9.2                           Restrictions on Debt. 26
     Section 9.3                      Restrictions on Dividends. 26
     Section 9.4   Restrictions on Transactions with Affiliates. 27
     Section 9.5                    Restrictions on Investments. 27
     Section 9.6Restrictions on Sale and Lease-Back Transactions.     27
     Section 9.7                Restrictions on Sales of Assets. 28
     Section 9.8                   Restrictions on Subsidiaries. 28
     Section 9.9                 Change in Business; Operations. 28
     Section 9.10         Exceptions With Consent of Purchasers. 28
SECTION 10.  MISCELLANEOUS.                                   28
     Section 10.1                                  Counterparts. 28
     Section 10.2                                      Headings. 28
     Section 10.3                                  Severability. 29
     Section 10.4                  Entire Agreement. Amendments. 29
     Section 10.5                                       Notices. 29
     Section 10.6                                      Interest. 29
     Section 10.7                        Successors and Assigns. 30
     Section 10.8                  No Third Party Beneficiaries. 30
     Section 10.9                                     Publicity. 30
     Section 10.10                           Further Assurances. 30
     Section 10.11                       No Strict Construction. 30
     Section 10.12                                Governing Law. 30

           CROSS-REFERENCE TO DEFINED TERMS

          Term                               Page where
defined
          1933 ACT                                1
          1934 ACT                                9
          ADDITIONAL CLOSING                      2
          ADDITIONAL CLOSING DATE                 2
          AGREEMENT                               1
          BRIDGE NOTES                            1
          BYLAWS                                  8
          CHANGE IN BUSINESS                     26
          CHARTER                                 8
          CLERK CERTIFICATE                       3
          CLOSING                                 2
          CLOSING DATE                            2
          COMMON STOCK                            1
          COMPANY                                 1
          COMPLIANCE CERTIFICATE                  3
          CONSENTS                               17
          CONVERSION SHARES                       1
          CYBERFIN                               13
          DEBT                                   23
          DISCLOSURE                              7
          ENVIRONMENTAL LAWS                     11
          ESCROW AGENT                            2
          ESCROW AGREEMENT                        3
          EXCESS CASH                            25
          FINANCIAL STATEMENTS                    9
          FIRST CLOSING                           2
          FIRST CLOSING DATE                      2
          GUARANTOR                              13
          GUARANTORS                             13
          GUARANTY                                3
          INDEMNIFIED LIABILITIES                23
          INDEMNITEES                            23
          KRUY                                   13
          MINIMUM AMOUNT                          2
          NASD                                   21
          OBLIGATIONS                             4
          PLEDGE AGREEMENTS                      13
          PLEDGED SECURITIES                      1
          PREFERRED STOCK                         8
          PROPORTIONATE                           6
          PURCHASE PRICE                          2
          PURCHASED BRIDGE NOTES                  2
          PURCHASER                               1
          REGISTRATION PERIOD                    20
          REGISTRATION RIGHTS AGREEMENT           1
          REGULATION D                            1
          REPRESENTATIVE                          4
          REPRICING SHARES                        1
          REPRICING WARRANT                       1
          RULE 144                               15
          SEC DOCUMENTS                           9
          SECURITIES                              7
          TRANSACTION AGREEMENTS                  7
          TRANSFER AGENT INSTRUCTIONS             3
          WARRANT SHARES                          1
          WARRANTS                                1

        SERIES 1 BRIDGE NOTE PURCHASE AGREEMENT

THIS SERIES 1 BRIDGE NOTE PURCHASE AGREEMENT (the
"Agreement") is made and entered into as of this 18th
day of January, 2000, among CAMBEX CORPORATION, a
Massachusetts corporation (the "Company") and the
persons listed on the Purchaser signature pages
attached hereto (each of whom is individually referred
to as a "Purchaser" and all of whom collectively are
referred to as the "Purchasers").

                      BACKGROUND
The Company has authorized the issuance, sale, and
delivery of up to $2,000,000 in original principal
amount of the Company's Series 1 Secured Convertible
Bridge Notes, in substantially the form attached hereto
as Exhibit A (the "Bridge Notes").  The Bridge Notes
are convertible into shares of the Company's common
stock, par value $.10 (the "Common Stock").  The Common
Stock issuable upon conversion of the Bridge Notes is
hereinafter referred to as the "Conversion Shares".
The Bridge Notes have attached repricing rights
evidenced by a warrant in substantially the form of
Attachment 1 to the Bridge Notes (the "Repricing
Warrant"), exercisable under certain circumstances for
additional shares of Common Stock (the "Repricing
Shares") at the exercise price of $.10.  In connection
with the issuance of the Bridge Notes, the Company has
authorized the issuance of Purchase Warrants, in
substantially the form attached hereto as Exhibit B
(the "Warrants") giving a Purchaser the right to
purchase Common Stock.  Each Purchaser will be issued a
Warrant at that Closing exercisable for 15,000 shares
of Common Stock for each $100,000 in principal amount
of Bridge Notes purchased.  The shares of Common Stock
issuable upon exercise of the Warrants are hereinafter
referred to as the "Warrant Shares." The proceeds of
the Bridge Notes will be used to provide the Company
with operating capital, repayment of certain limited
existing indebtedness of the Company, and capital
expenditures.  The Bridge Notes are generally secured
by 1,709,467 shares of the Company's Common Stock (the
"Pledged Securities") owned or held by certain Company
officers or corporations controlled by them and pledged
as part of their limited guaranty of the Company's
Obligations hereunder.  Purchasers wish to purchase,
upon the terms and conditions stated in this Agreement,
up to $2,000,000 in principal amount of the Bridge
Notes, with each Purchaser purchasing Bridge Notes in
the principal amount set forth on such Purchaser's
signature page affixed to this Agreement.
Contemporaneously with the execution and delivery of
this Agreement, the parties hereto are executing and
delivering a Registration Rights Agreement in
substantially the form attached hereto as Exhibit C
(the "Registration Rights Agreement") pursuant to which
the Company has agreed to provide certain registration
rights in respect of the Conversion Shares, the Warrant
Shares, and the Repricing Shares under the Securities
Act of 1933 ("1933 Act") and the rules and regulations
promulgated thereunder, and applicable state securities
laws.  The Company and the Purchasers are executing and
delivering this Agreement in reliance upon the
exemption from securities registration pursuant to
Section 4(2) and Regulation D ("Regulation D").

                       AGREEMENT

For and in consideration of the premises and the mutual
covenants contained herein and other good and valuable
consideration, the receipt and sufficiency of which are
hereby acknowledged, the Company and each Purchaser
hereby agree as follows:

SECTION 1.     bridge notes.

Section 1.1    Authorization, Issuance, and Sale of
Notes.
The Company has authorized the sale and issuance, in
accordance with the terms of this Agreement, of up to
$2,000,000 in principal amount of its Bridge Notes at
one or more closings.  The Company agrees to issue and
sell to each Purchaser and each Purchaser agrees to
purchase from the Company, at a Closing, a Bridge Note
in the principal amount (the "Purchased Bridge Notes")
set forth adjacent to the caption "Purchased Bridge
Notes" on the signature page to this Agreement of each
Purchaser hereto at a purchase price (the "Purchase
Price") of 100% of the principal amount of Bridge Notes
purchased.

Section 1.2    Authorization and Issuance of Warrants.

     The Company has authorized the issuance and
delivery of Warrants exercisable for up to 300,000
shares of Common Stock in connection with the issuance,
sale, and delivery of the Bridge Notes.  The Company
agrees to issue and deliver to each Purchaser a Warrant
exercisable in accordance with its terms for 15,000
shares of Common Stock for each $100,000 in principal
amount of the Bridge Notes purchased by such Purchaser.

Section 1.3    Form of Payment.
On or before the Closing Date, each Purchaser shall pay
the Purchase Price for the Purchased Bridge Notes to be
issued and sold to such Purchaser at the Closing, by
wire transfer of immediately available funds to:
               Bank:             SunTrust Bank, Atlanta
               Center:           008
               Account No.:      9088000008
               ABA Routing No.:  061000104
               Attn:             Rebecca Fischer
               Re:               Cambex Corporation-
                                 Escrow Account

Section 1.4    Closing.
All closings of the purchase and sale of the Purchased
Bridge Notes shall take place at the offices of Balboni
Law Group LLC, 3475 Lenox Road, NE, Suite 990, Atlanta,
Georgia 30326, within five (5) business days following
the date that $1,000,000 (the "Minimum Amount") is held
by SunTrust Bank, Atlanta (the "Escrow Agent"), subject
to notification of satisfaction (or waiver) of the
conditions to the Closing set forth in Section 5 below
(such closing being called the "First Closing" and such
date and time being called the "First Closing Date").
Following the First Closing, the Company anticipates it
will continue to offer the Bridge Notes until the
offering of the Bridge Notes is terminated or all
$2,000,000 in principal amount is purchased.  From time
to time, one or more additional closings may occur at
such time and date as is mutually agreeable between the
Purchasers purchasing Bridge Notes at such closing and
the Company (each such closing being called an
"Additional Closing" and such date and time being
called an "Additional Closing Date," and all of such
closings are hereinafter referred to individually as a
"Closing" and collectively as the "Closings," and each
date on which a Closing shall occur is hereinafter
referred to as a "Closing Date" and collectively as the
"Closing Dates").  Each Closing is expected to take
place by exchange of faxed signature pages with
originals to follow by overnight delivery.

Section 1.5    Deliveries at Closing.
At each Closing the Company shall deliver to the
Purchasers:
     (a)  the original of this Agreement;
     (b)  Bridge Notes in definitive form with
     attached Repricing Warrants, registered in
     the name of each Purchaser, or the designee
     of such Purchaser, representing the Purchased
     Bridge Notes purchased by such Purchaser;
     (c)  Warrants in definitive form, registered
     in the name of each Purchaser, or the
     designee of such Purchaser;
     (d)  a copy of the Registration Rights
     Agreement;
     (e)  a copy of the Escrow Agreement in
     substantially the form of Exhibit D hereto
     (the "Escrow Agreement");
     (f)  a Guaranty Agreement (the "Guaranty")
     executed by the Company and the pledgor of
     stock representing Pledged Securities as
     Guarantor thereunder, and an accompanying
     Stock Pledge Agreement executed by pledgor of
     stock representing Pledged Securities as
     pledgor of certain shares or rights to
     acquire shares of Common Stock of the Company
     for a particular Closing;
     (g)  stock certificates or evidence of the
     shares in DTC form representing the Pledged
     Securities;
     (h)  a copy of the opinion of counsel to the
     Company, in substantially the form of Exhibit
     E hereto;
     (i)  a copy of the Irrevocable Transfer Agent
     Instructions, in substantially the form of
     Exhibit F  hereto, (the "Transfer Agent
     Instructions");

          (j)  the Compliance Certificate of the
     Company (the "Compliance Certificate"); and
     (k)  the Clerk Certificate of the Company
     (the "Clerk Certificate").

Section 1.6    Deliveries by Guarantors at Closing.
At the First Closing the Guarantors shall deliver:
     (a)  to the Purchasers, an executed copy of
     each of this Agreement and their respective
     Guaranty Agreement and Stock Pledge
     Agreement; and
     (b)  to an escrow agent or a brokerage
     designated by Purchasers pursuant to the
     Stock Pledge Agreements, original
     certificates in the names of the Guarantors
     with attached executed stock powers in blank,
     or evidence of receipt by such brokerage of
     DTC shares of the Company representing the
     Collateral Shares registered with the
     Company's transfer agent in the name of the
     Purchasers.

SECTION 2.     pledged shares; appointment of
representative.
The provisions of this Section 2 shall remain in effect
so long as any of the Bridge Notes shall remain
outstanding.

Section 2.1    Pledged Shares.
In order to secure the obligations of the Company due
to the Purchasers (such obligations are sometimes
hereinafter referred to as the "Obligations") under the
Transaction Agreements (as defined below), Guarantors
have pledged pursuant to their respective Guaranty
Agreement and Stock Pledge Agreement, effective at the
First Closing, a continuing first priority interest in
and to the Pledged Shares.

Section 2.2    Appointment of Purchaser Representative.
Each Purchaser hereto hereby irrevocably appoints
SovCap Equity Partners, Ltd., a corporation organized
under the laws of the Bahamas and a First Closing
Purchaser hereunder, to act as the sole and exclusive
agent and representative (the "Representative") of each
such Purchaser to act on behalf of such Purchaser and
in such Purchaser's name, place, and stead, to
(i) exercise all rights of such Purchaser, and
(ii) take all action on behalf of Purchaser that may be
taken by Purchaser with respect to the collateral under
this Agreement, the Bridge Notes, and the other
Transaction Agreements.  Without limiting the
generality of the foregoing:
     (a)  The Representative shall, on behalf of
     all Purchasers, send all notices which shall
     or may be given by Purchasers, under the
     Transaction Agreements, declare Events of
     Default under this Agreement, the Bridge
     Notes, and the other Transaction Agreements,
     accelerate the Bridge Notes, rescind
     acceleration of the Bridge Notes, and enforce
     the Bridge Notes, this Agreement, and the
     other Transaction Agreements.  The
     Representative reserves the right, in its
     sole discretion, in each instance without
     prior notice to the Purchasers, (i) to agree
     to the modification, waiver, or release of
     any of the terms of any of the Transaction
     Agreements, including, without limitation,
     the waiver or release of any of the
     conditions precedent for the purchase and
     sale of the Bridge Notes; (ii) to consent to
     any action or failure to act by the Company;
     and (iii) to exercise or refrain from
     exercising any powers, rights, or remedies
     that the Purchasers have or may have with
     respect to collateral under the Transaction
     Agreements; provided however, that the
     Representative shall not, without obtaining
     the prior written consent of each Purchaser
     (which consent shall not be unreasonably
     withheld or delayed), exercise any of such
     rights so as to knowingly release or waive
     any claim against the Company or any other
     person who may be liable with respect to the
     Bridge Notes if such action would have a
     materially adverse effect on the collection
     of the indebtedness evidenced by the Bridge
     Notes or the enforcement of the Transaction
     Agreements.
     If any Purchaser shall refuse to consent to
     any amendment, modification, waiver, release,
     or subordination requiring the written
     consent of the Purchasers, the Purchasers who
     consent to such amendment, modification,
     waiver, release, or subordination may, at
     their option, at any time thereafter (but
     shall not be obligated to) purchase the
     Bridge Note or Bridge Notes held by the non-
     consenting Purchaser or Purchasers by paying
     to such non-consenting Purchaser or
     Purchasers an amount equal to the unpaid
     principal and accrued but unpaid interest on
     the Bridge Note held by such non-consenting
     Purchaser or Purchasers.
     (b)  The Representative shall collect,
     enforce, and bring any action on the
     Transaction Agreements and any collateral
     granted therein in the name of the
     Representative for the benefit of all
     Purchasers, in accordance with this Section
     2.

Section 2.3    Assurances.
     (a)  Each Purchaser hereby authorizes third
     parties with whom Representative deals in
     carrying out the responsibilities of
     Representative hereunder, to rely
     conclusively on the instructions and
     decisions of the Representative as to any
     action taken pursuant to and in accordance
     with the terms of this Agreement and the
     other Transaction Agreements without any
     further or additional approval or
     authorization from such Purchaser, including
     without limitation, the execution and
     delivery of any documents or instruments, or
     any other actions required to be taken by the
     Representative under this Agreement and the
     other Transaction Agreements, and no
     Purchaser shall have any cause of action
     against third parties with whom
     Representative deals in carrying out the
     responsibilities of Representative hereunder
     or under the other Transaction Agreements for
     any action taken by such third parties in
     reliance upon the instructions or decisions
     of the Representative;
     (b)  All actions, decisions, and instructions
     of the Representative shall be conclusive and
     binding upon all of the Purchasers, and no
     Purchaser shall have any cause of action
     against the Representative for any actions
     taken, decision made or instruction given by
     the Representative under this Agreement,
     except for fraud or willful misconduct by
     Representative acting in such capacity
     hereunder.

Section 2.4    Default and Acceleration Procedures.
     (a)  Each Purchaser acknowledges and agrees
     that its respective rights in, to, and under
     the Pledged Shares provided for in the
     Guaranty Agreements and Stock Pledge
     Agreements are limited to the Pledged Shares
     securing the Bridge Notes purchased by each
     such Purchaser as granted by the Guarantors
     pursuant to the First Closing. Purchasers and
     Representative acknowledge and agree that the
     Pledged Shares shall secure all Bridge Notes
     issued hereunder on a pro-rata basis and upon
     a continuing Event of Default Purchasers
     shall be entitled to a Proportionate Share in
     the event Representative deems it necessary
     to take action with respect to the Pledged
     Shares.
     (b)  The Representative shall give all
     Purchasers written notice of any Event of
     Default under the Bridge Notes, this
     Agreement, or the other Transaction
     Agreements which, in the judgment of the
     Representative, adversely affects the
     respective interests of the Purchasers under
     any of the Transaction Agreements.  In the
     event of any Event of Default thereunder, the
     Representative shall pursue any remedies
     available to Purchasers under the Transaction
     Agreements which the Representative in its
     sole discretion shall deem advisable, and
     Representative may also elect to postpone the
     pursuit of remedies if in its sole discretion
     and judgment it is appropriate under the
     circumstances to do so.
     (c)  In the event proceedings are instituted
     for a sale under power of sale or a judicial
     foreclosure of the collateral provided under
     the Transaction Agreements, the provisions of
     the Massachusetts UCC, absent written
     agreement to the contrary, shall govern such
     proceedings and the actions taken pursuant
     thereto, as among the Representative and the
     Purchasers.
     (d)  In the event the Representative acquires
     title to any of the collateral provided under
     the Transaction Agreements pursuant to a
     foreclosure or conveyance in lieu of
     foreclosure, title shall be taken in a form
     acceptable to the Representative and shall be
     held by or on behalf of the Representative
     for the benefit of only the Purchasers
     holding Bridge Notes which were secured by
     such collateral, in their Proportionate
     Share.  The Representative shall manage such
     collateral in its ordinary course of business
     and in accordance with its customary
     practices and procedures for as long as such
     title is held in whole or in part in the name
     of or on behalf of the Representative.  The
     Representative shall contemporaneously
     endeavor to sell such collateral on terms and
     conditions reasonably acceptable to the
     Representative.
     (e)  If the Representative receives a payment
     after acceleration of the Bridge Notes,
     whether pursuant to a demand for payment or
     as a result of legal proceedings against the
     Company, or from any source whatsoever, such
     payment in respect of the specific Bridge
     Notes so paid shall be applied in the
     following order (unless mandated otherwise by
     the Transaction Agreements or validly by the
     express terms of such payment):

              (1)  To the expenses incurred in
         effecting such recovery or in enforcing any
         right or remedy under the Transaction
         Agreements, and any other expenses
         theretofore incurred by the Representative
         and not previously reimbursed by the Company;

              (2)  To accrued interest, payable by the
         Company, according to Purchaser's
         Proportionate Share of such accrued interest
         in respect of such Bridge Notes; and

              (3)  To the unpaid principal of such
         Bridge Notes with each Purchaser receiving
         such Purchaser's Proportionate Share of such
         principal.
     (f)  The term "Proportionate Share" shall
     mean the amount of each Purchaser's Bridge
     Note purchased at a specific Closing divided
     by the total amount of Bridge Notes issued
     under and pursuant to this Agreement.

Section 2.5    Standard of Care of the Representative.
     (a)  The Representative shall endeavor in
     good faith to perform all services and duties
     and exercise all powers hereunder
     specifically assigned and delegated to the
     Representative, and the Representative shall
     perform and exercise, and shall have the
     right and power to perform and exercise, such
     other services and powers as are reasonably
     incidental thereto.  The Representative shall
     not be liable to the Purchasers, however, for
     any action or failure to act or any error of
     judgment, negligence, mistake, or oversight
     by it or any of its agents, officers,
     employees, or attorneys, with respect to the
     Transaction Agreements, provided the
     Representative has acted in good faith and
     has not been guilty of willful misconduct or
     gross negligence.  Without limiting the
     generality of the foregoing, the
     Representative may consult with counsel or
     other advisors selected by it, and the
     Representative shall not be liable for any
     action taken or omitted to be taken in good
     faith by it in accordance with the advice of
     such counsel or other advisors.  In
     performing its obligations hereunder and
     under the Transaction Agreements, the
     Representative may rely in good faith on
     written and telephonic communications
     received by the Representative without
     investigating the genuineness thereof or the
     power and authority of the author of such
     communications.  Each Purchaser acknowledges
     and agrees that the Representative's duties
     and obligations under this Agreement are
     administrative and ministerial in nature, and
     that the Representative has no fiduciary
     obligation to the Purchasers.
     (b)  The Representative does not assume, and
     shall not have, any responsibility or
     liability, express or implied, for the
     adequacy, sufficiency, validity,
     collectability, genuineness, or
     enforceability of any of the Transaction
     Agreements, for the financial condition of
     the Company, for compliance by the Company
     with the terms and conditions of the
     Transaction Agreements, or for the accuracy
     of any financial or other information
     furnished to the Purchaser by the
     Representative or by any other party.  The
     Representative shall not be required to
     ascertain or inquire as to the performance or
     observance by the Company of any of the
     terms, conditions, provisions, covenants, or
     agreements contained in any of the
     Transaction Agreements or as to the use of
     the proceeds of the offering of the Bridge
     Notes or of the existence or possible
     existence of any Event of Default thereunder.
     (c)  The Representative may accept deposits
     from, lend money to, and generally engage in
     any kind of banking, trust, financial
     advisory, or other business with the Company
     or any affiliate thereof as if it were not
     performing the duties specified herein, and
     may accept fees and other consideration from
     the Company or affiliate for services in
     connection with such services, without having
     to account for the same to the Purchasers."

SECTION 3.     REPRESENTATIONS AND WARRANTIES OF THE
COMPANY.
To induce the Purchasers to purchase the Bridge Notes,
the Company represents and warrants to each Purchaser,
except as referenced on Schedule 1 hereto (the
"Disclosure Schedule"), which reference shall set forth
the specific section to which the qualification relates
and the statement which constitutes the qualification,
that:

Section 3.1    Organization and Qualification.
The Company and its subsidiaries are corporations duly
organized, validly existing, and in good standing under
the laws of the jurisdiction in which they are
incorporated, and have the requisite corporate power to
own their properties and to carry on their business as
now being conducted.  Each of the Company and each
subsidiary is duly qualified as a foreign corporation
to do business and is in good standing in each
jurisdiction in which the nature of the business
conducted by it makes such qualification necessary,
except to the extent that the failure to be so
qualified or be in good standing would not have a
material adverse effect on the Company and its
subsidiaries taken as a whole.

Section 3.2    Authorization, Enforcement, Compliance
with Other Instruments.
     (a)  The Company has the requisite corporate
     power and authority to enter into and perform
     each of this Agreement, any and all
     amendments thereto, the Bridge Notes, the
     Repricing Warrants, the Warrants, the
     Registration Rights Agreement, the Escrow
     Agreement, the individual guaranties and
     stock pledge agreements of each of Joseph
     Kruy and Cyberfin Corp., a Massachusetts
     corporation, on behalf of Peter Kruy, the
     Transfer Agent Instructions, the Financing
     Statement, and any related agreements
     (collectively, the "Transaction Agreements"
     and individually a "Transaction Agreement"),
     and to issue the Bridge Notes, the Repricing
     Warrants, the Warrants, the Conversion
     Shares, the Repricing Shares, and the Warrant
     Shares in accordance with the terms hereof
     and thereof;
     (b)  the execution and delivery by the
     Company of each of the Transaction Agreements
     and the consummation by it of the
     transactions contemplated thereby, including
     without limitation the issuance of the Bridge
     Notes, the Warrants, and the Repricing
     Warrants, the reservation for issuance and
     the issuance of the Conversion Shares
     issuable upon conversion of the Bridge Notes
     and the reservation for issuance and the
     issuance of the Repricing Shares, and the
     Warrant Shares, upon exercise of the
     Repricing Warrants, and the Warrants (the
     Bridge Notes, the Repricing Warrants, the
     Warrants, the Conversion Shares, the
     Repricing Shares, and the Warrant Shares are
     hereinafter collectively, the "Securities")
     have been duly authorized by the Company's
     Board of Directors and no further consent or
     authorization is required by the Company, its
     Board of Directors, or its stockholders;
     (c)  each of the Transaction Agreements have
     been duly and validly executed and delivered
     by the Company; and
     (d)  each of the Transaction Agreements
     constitutes the valid and binding obligation
     of the Company enforceable against the
     Company in accordance with its terms, except
     as such enforceability may be limited by
     general principles of equity or applicable
     bankruptcy, insolvency, reorganization,
     moratorium, liquidation, or similar laws
     relating to, or affecting generally, the
     enforcement of creditors' rights and
     remedies.

Section 3.3    Capitalization.
Immediately prior to Closing, the authorized capital
stock of the Company consisted of 28,000,000 shares of
capital stock, of which 25,000,000 shares are Common
Stock, par value $.10, of which 9,545,176 shares were
issued and outstanding as of the date of this
Agreement, and 3,000,000 shares of preferred stock
("Preferred Stock"), par value $1.00, none of which are
issued and outstanding.  All of such outstanding shares
have been validly issued and are fully paid and
nonassessable.  Except as described in Section 3.3 of
the Disclosure Schedule, no shares of Common Stock or
Preferred Stock are subject to preemptive rights or any
other similar rights or any liens or encumbrances
suffered or permitted by the Company.  Except as
disclosed in Section 3.3 of the Disclosure Schedule, as
of the effective date of this Agreement, (a) there are
no outstanding options, warrants, scrip, rights to
subscribe to, calls, or commitments of any character
whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the
Company or any of its subsidiaries, or contracts,
commitments, understandings, or arrangements by which
the Company or any of its subsidiaries is or may become
bound to issue additional shares of capital stock of
the Company or any of its subsidiaries, or options,
warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or
securities or rights convertible into, any shares of
capital stock of the Company or any of its
subsidiaries, (b) there are no outstanding debt
securities, and (c) there are no agreements or
arrangements under which the Company or any of its
subsidiaries is obligated to register the sale of any
of their securities under the 1933 Act (except the
Registration Rights Agreement).  There are no
securities or instruments containing anti-dilution or
similar provisions that will be triggered by the
issuance of the Securities in the manner contemplated
by this Agreement.  The Company has furnished to the
Purchaser true and correct copies of the Company's
Articles of Organization, as amended (the "Charter")
and the Company's Bylaws, as in effect on the date
hereof (the "Bylaws"), and the terms of all securities
convertible into or exercisable for Common Stock and
the material rights of the holders thereof in respect
thereto.

Section 3.4    Issuance of Securities.

     The Bridge Notes have been duly authorized and are
free from all taxes, liens, and charges with respect to
the issue thereof.  The Conversion Shares issuable upon
conversion of the Bridge Notes have been duly
authorized and reserved for issuance.  The Repricing
Warrants have been duly authorized and are free from
all taxes, liens, and charges with respect to the
issuance thereof.  The Repricing Shares issuable upon
exercise of the Repricing Warrants have been duly
authorized and reserved for issuance.  The Warrants
have been duly authorized and are free from all taxes,
liens, and charges with respect to the issuance
thereof.  The Warrant Shares issuable upon exercise of
the Warrants have been duly authorized and reserved for
issuance. Upon conversion of the Bridge Notes, the
Conversion Shares will, and upon exercise of the
Repricing Warrants, and the Warrants, the Repricing
Shares, and the Warrant Shares will, be duly and
validly issued, fully paid, and nonassessable, and free
from all taxes, liens, and charges, with respect to the
issuance thereof, with the holders being entitled to
all rights accorded to a holder of Common Stock.

Section 3.5    No Conflicts.
Except as disclosed in Section 3.5 of the Disclosure
Schedule, the execution, delivery, and performance of
the Transaction Agreements by the Company, and the
consummation by the Company of the transactions
contemplated thereby, will not (a) result in a
violation of the Charter or the Bylaws of the Company
or (b) conflict with, constitute a default (or an event
which with notice or lapse of time or both would become
a default) under, or give to others any rights of
termination, amendment, acceleration, or cancellation
of, any agreement, indenture, or instrument to which
the Company or any of its subsidiaries is a party, or
result in a violation of any law, rule, regulation,
order, judgment, or decree (including federal and state
securities laws and regulations and the rules and
regulations of the principal market or exchange on
which the Common Stock is traded or listed) applicable
to the Company or any of its subsidiaries or by which
any property or asset of the Company or any of its
subsidiaries is bound or affected.  Except as described
in Section 3.5 of the Disclosure Schedule, neither the
Company nor any subsidiary is in violation of any term
of, or in default under, its Charter or the Bylaws or
their organizational charter or Bylaws, respectively,
or any material contract, agreement, mortgage,
indebtedness, indenture, instrument, judgment, decree,
or order or any statute, rule, or regulation applicable
to the Company or its subsidiaries.  The business of
the Company and its subsidiaries is not being conducted
in violation of any law, ordinance, or regulation of
any governmental entity.  Except as specifically
contemplated by this Agreement and as required under
the 1933 Act and any applicable state securities laws,
the Company is not required to obtain any consent,
authorization, or order of, or make any filing or
registration with, any court or governmental agency in
order for it to execute, deliver, and perform any of
its obligations under or contemplated by the
Transaction Agreements in accordance with the terms
thereof.  Except as disclosed in Section 3.5 of the
Disclosure Schedule, all consents, authorizations,
orders, filings, and registrations which the Company is
required to obtain pursuant to the preceding sentence
have been obtained or effected on or prior to the date
hereof.  The Company and its subsidiaries are unaware
of any facts or circumstances which might give rise to
any of the foregoing.

Section 3.6    SEC Documents;  Financial Statements.
Since November 12, 1999, the Company has filed all
reports, schedules, forms, statements, and other
documents required to be filed by it with the SEC
pursuant to the reporting requirements of the
Securities Exchange Act of 1934, as amended (the "1934
Act") (all of the foregoing filed prior to the date
hereof and all exhibits included therein and financial
statements and schedules thereto and documents
incorporated by reference therein, being hereinafter
referred to as the "SEC Documents").  The Company has
made available to each Purchaser or its representative
true and complete copies of the SEC Documents.  The
Company (i) is a "reporting issuer" as defined in Rule
902(1) of Regulation S and (ii) has a class of
securities registered under Section 12(b) or 12(g) of
the 1934 Act or is required to file reports pursuant to
Section 15(d) of the 1934 Act, and has filed all the
materials required to be filed as reports pursuant to
the Exchange Act for the period the Company was
required by law to file such material.  As of their
respective dates, the financial statements of the
Company included in the SEC Documents (the "Financial
Statements") complied as to form in all material
respects with applicable accounting requirements and
the published rules and regulations of the SEC with
respect thereto.  Such financial statements have been
prepared in accordance with generally accepted
accounting principles, consistently applied, during the
periods involved (except (a) as may be otherwise
indicated in such financial statements or the notes
thereto, or (b) in the case of unaudited interim
statements, to the extent they may exclude footnotes or
may be condensed or summary statements) and present
fairly, in all material respects, the financial
position of the Company as of the dates thereof, and
the results of its operations and cash flows for the
periods then ended (subject, in the case of unaudited
statements, to normal year-end audit adjustments).  No
other information provided by or on behalf of the
Company to the Purchaser which is not included in the
SEC Documents, including, without limitation,
information referred to in Section 3.5 of this
Agreement, contains any untrue statement of a material
fact or omits to state any material fact necessary in
order to make the statements therein, in the light of
the circumstance under which they are or were made, not
misleading.

Section 3.7    Absence of Certain Changes.
Except as described in Section 3.7 of the Disclosure
Schedule, since the date of the most recent audited
balance sheet included in the SEC Documents, there has
been no material adverse change and no material adverse
development in the business, properties, operations,
financial condition, results of operations, or
prospects of the Company or its subsidiaries.  The
Company has not taken any steps, and does not currently
expect to take any steps, to seek protection pursuant
to any bankruptcy law nor does the Company or its
subsidiaries have any knowledge that its creditors
intend to initiate involuntary bankruptcy proceedings.

Section 3.8    Absence of Litigation.
There is no action, suit, proceeding, inquiry, or
investigation before or by any court, public board,
government agency, self-regulatory organization, or
body pending or, to the knowledge of the Company or any
of its subsidiaries, threatened against or affecting
the Company, the Common Stock, or any of the Company's
subsidiaries, wherein an unfavorable decision, ruling
or finding would (a) have a material adverse effect on
the transactions contemplated hereby, (b) adversely
affect the validity or enforceability of, or the
authority or ability of the Company to perform its
obligations under the Transaction Agreements, or (c)
except as expressly set forth in Schedule 3.8 of the
Disclosure Schedule, have a material adverse effect on
the business, operations, properties, financial
condition, or results of operation of the Company and
its subsidiaries taken as a whole.

Section 3.9    Purchase of Securities.
The Company acknowledges and agrees that the Purchaser
is acting solely in the capacity of an arm's length
purchaser with respect to this Agreement and the
transactions contemplated hereby.  The Company further
acknowledges that the Purchaser is not acting as a
financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to this Agreement
and the transactions contemplated hereby and any advice
given by the Purchasers or any of their respective
representatives or agents in connection with this
Agreement and the transactions contemplated hereby is
merely incidental to such Purchaser's purchase of the
Securities.  The Company further represents to the
Purchaser that the Company's decision to enter into
this Agreement has been based solely on the independent
evaluation by the Company and its representatives.

Section 3.10   No Undisclosed Events, Liabilities,
Developments, or Circumstances.
No event, liability, development, or circumstance has
occurred or exists, or to the knowledge of the Company
is contemplated to occur, with respect to the Company
or its subsidiaries or their respective business,
properties, prospects, operations, or financial
condition, which could be material but which has not
been publicly announced or disclosed in writing to the
Purchaser.

Section 3.11   No General Solicitation.
Neither the Company, nor any of its affiliates, nor any
person acting on its or their behalf, has engaged in
any form of general solicitation or general advertising
(within the meaning of Regulation D under the 1933 Act)
in connection with the offer or sale of the Bridge
Notes or the Conversion Shares.  The Company represents
that it has not offered the Bridge Notes or Conversion
Shares to the Purchaser in the U.S. or, to the best
knowledge of the Company, to any person in the United
States or any U.S. person.

Section 3.12   No Integrated Offering.
Neither the Company, nor any of its affiliates, nor any
person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or
solicited any offers to buy any security, under
circumstances that would require registration of any of
the Securities under the 1933 Act or cause this
offering to be integrated with prior offerings by the
Company for purposes of the 1933 Act or any applicable
stockholder approval provisions.

Section 3.13   Employee Relations.
Neither the Company nor any of its subsidiaries is
involved in any labor dispute nor, to the knowledge of
the Company or any of its subsidiaries, is any such
dispute threatened.  None of the Company's or its
subsidiaries' employees is a member of a union and the
Company and its subsidiaries believe that their
relations with their employees are good.

Section 3.14   Intellectual Property Rights.
The Company and its subsidiaries own or possess
adequate rights or licenses to use all trademarks,
trade names, service marks, service mark registrations,
service names, patents, patent rights, copyrights,
inventions, licenses, approvals, governmental
authorizations, trade secrets, and rights necessary to
conduct their respective businesses as now conducted.
Except as set forth on Section 3.14 of the Disclosure
Schedule, none of the Company's trademarks, trade
names, service marks, service mark registrations,
service names, patents, patent rights, copyrights,
inventions, licenses, approvals, government
authorizations, trade secrets, or other intellectual
property rights have expired or terminated, or are
expected to expire or terminate in the near future,
other than those that would not have a material adverse
effect on the Company.  The Company and its
subsidiaries do not have any knowledge of any
infringement by the Company or its subsidiaries of the
trademark, trade name rights, patents, patent rights,
copyrights, inventions, licenses, service names,
service marks, service mark registrations, trade
secret, or other similar rights of others. Except as
set forth on Section 3.14 of the Disclosure Schedule,
there is no claim, action, or proceeding being made or
brought against, or to the Company's knowledge, being
threatened against, the Company or its subsidiaries
regarding trademark, trade name, patents, patent
rights, invention, copyright, license, service names,
service marks, service mark registrations, trade
secret, or other infringement, and the Company and its
subsidiaries are unaware of any facts or circumstances
which might give rise to any of the foregoing.  The
Company and its subsidiaries have taken reasonable
security measures to protect the secrecy,
confidentiality, and value of all of their intellectual
properties.

Section 3.15   Environmental Laws.
The Company and its subsidiaries are (a) in compliance
with any and all applicable foreign, federal, state,
and local laws and regulations relating to the
protection of human health and safety, the environment,
or hazardous, toxic substances, wastes, pollutants, or
contaminants ("Environmental Laws"), (b) have received
all permits, licenses, or other approvals required of
them under applicable Environmental Laws to conduct
their respective businesses, and (c) are in compliance
with all terms and conditions of any such permit,
license, or approval.

Section 3.16   Title.
The Company and its subsidiaries have good and
marketable title in fee simple to all real property and
good and marketable title to all personal property
owned by them which is material to the business of the
Company and its subsidiaries, in each case free and
clear of all liens, encumbrances, and defects except as
described in Section 3.16 of the Disclosure Schedule or
as do not materially affect the value of such property
and do not interfere with the use made and proposed to
be made of such property by the Company and its
subsidiaries.  Any real property and facilities held
under lease by the Company and its subsidiaries are
held by them under valid, subsisting, and enforceable
leases with such exceptions as are not material, and do
not interfere with the use made and proposed to be made
of such property and buildings by the Company and its
subsidiaries.

Section 3.17   Insurance.

     The Company and each of its subsidiaries are
insured by insurers of recognized financial
responsibility against such losses and risks, and in
such amounts, as management of the Company believes to
be prudent and customary in the businesses in which the
Company and its subsidiaries are engaged.  Neither the
Company nor any such subsidiary has been refused any
insurance coverage sought or applied for, and neither
the Company nor any such subsidiary has any reason to
believe that it will not be able to renew its existing
insurance coverage as and when such coverage expires or
to obtain similar coverage from similar insurers as may
be necessary to continue its business at a cost that
would not materially and adversely affect the
condition, financial, or otherwise, or the earnings,
business, or operations of the Company and its
subsidiaries, taken as a whole.

Section 3.18   Regulatory Permits.
The Company and its subsidiaries possess all
certificates, authorizations, and permits issued by the
appropriate federal, state, or foreign regulatory
authorities necessary to conduct their respective
businesses, except to the extent that the failure to
possess any such certificate, authorization, and permit
would not have a material adverse effect on the Company
and its subsidiaries taken as a whole, and neither the
Company nor any such subsidiary has received any notice
of proceedings relating to the revocation or
modification of any such certificate, authorization, or
permit.

Section 3.19   Internal Accounting Controls.
The Company and each of its subsidiaries maintain a
system of internal accounting controls sufficient to
provide reasonable assurance that (a) transactions are
executed in accordance with management's general or
specific authorizations, (b) transactions are recorded
as necessary to permit preparation of financial
statements in conformity with generally accepted
accounting principles and to maintain asset
accountability, (c) access to assets is permitted only
in accordance with management's general or specific
authorization, and (d) the recorded accountability for
assets is compared with the existing assets at
reasonable intervals and appropriate action is taken
with respect to any differences.

Section 3.20   No Materially Adverse Contracts, Etc.
Neither the Company nor any of its subsidiaries is
subject to any charter, corporate, or other legal
restriction, or any judgment, decree, order, rule, or
regulation which in the judgment of the Company's
officers has, or to the knowledge of the Company is
expected in the future to have, a material adverse
effect on the business, properties, operations,
financial condition, results of operations, or
prospects of the Company or its subsidiaries.  Neither
the Company nor any of its subsidiaries is a party to
any contract or agreement which in the judgment of the
Company's officers has, or to the knowledge of the
Company is expected to have, a material adverse effect
on the business, properties, operations, financial
condition, results of operations, or prospects of the
Company or its subsidiaries.

Section 3.21   Tax Status.
Except as set forth on Section 3.21 of the Disclosure
Schedule, the Company and each of its subsidiaries has
made or filed all federal and state income and all
other tax returns, reports, and declarations required
by any jurisdiction to which it is subject (unless and
only to the extent that the Company and each of its
subsidiaries has set aside on its books provisions
reasonably adequate for the payment of all unpaid and
unreported taxes), and has paid all taxes and other
governmental assessments and charges that are material
in amount, shown or determined to be due on such
returns, reports, and declarations, except those being
contested in good faith, and has set aside on its books
amounts deemed reasonably adequate for the payment of
all taxes for periods subsequent to the periods to
which such returns, reports, or declarations apply.
There are no unpaid taxes in any material amount
claimed to be due by the taxing authority of any
jurisdiction, and the officers of the Company know of
no basis for any such claim, and except as set forth on
Schedule 3.21, there are no open years, examinations in
progress or claims against it for federal, state or
other taxes (including penalties and interest) for any
period or periods prior to the date hereof.

Section 3.22   Certain Transactions.
Except as set forth on Section 3.22 of the Disclosure
Schedule and in the SEC Documents, and except for arm's
length transactions pursuant to which the Company makes
payments in the ordinary course of business upon terms
no less favorable than the Company could obtain from
third parties and other than the grant of stock options
disclosed on Section 3.3 of the Disclosure Schedule,
none of the officers, directors, or employees of the
Company is presently a party to any transaction with
the Company (other than for services as employees,
officers, and directors), including any contract,
agreement, or other arrangement providing for the
furnishing of services to or by, providing for rental
of real or personal property to or from, or otherwise
requiring payments to or from any officer, director, or
such employee or, to the knowledge of the Company, any
corporation, partnership, trust, or other entity in
which any officer, director, or any such employee has a
substantial interest or is an officer, director,
trustee, or partner.

Section 3.23   Dilutive Effect.
The Company understands and acknowledges that the
number of Conversion Shares issuable upon conversion of
the Bridge Notes will increase in certain
circumstances.  The Company further acknowledges that
its obligation to issue Conversion Shares upon
conversion of the Bridge Notes in accordance with this
Agreement and the Bridge Notes is absolute and
unconditional regardless of the dilutive effect that
such issuance may have on the ownership interests of
other stockholders of the Company.

Section 3.24   Fees and Rights of First Refusal.
The Company is not obligated to offer the securities
offered hereunder on a right of first refusal basis or
otherwise to any third parties including, but not
limited to, current or former shareholders of the
Company, underwriters, brokers, agents, or other third
parties.

Section 3.25   Foreign Corrupt Practices Act.
The Company has not made, offered, or agreed to offer
anything of value to any government official, political
party, or candidate for government office nor has it
taken any action which would cause the Company to be in
violation of the Foreign Corrupt Practices Act of 1977.

Section 3.26   Disclosure.
Neither this Agreement nor any Schedule or Exhibit
hereto, contains an untrue statement of a material fact
or omits a material fact necessary to make the
statements contained herein or therein not misleading.
None of the statements, documents, certificates or
other items prepared or supplied by the Company with
respect to the transactions contemplated hereby
contains an untrue statement of a material fact or
omits a material fact necessary to make the statements
contained therein not misleading.

     section 4. REPRESENTATIONS AND WARRANTIES OF THE
GUARANTORs.
To induce the Purchasers to purchase the Bridge Notes,
each of Joseph Kruy ("Kruy"), an individual resident of
the Commonwealth of Massachusetts and Cyberfin Corp.
("Cyberfin"), a Massuchetts corporation owned and
controlled by Peter Kruy (each of Kruy and Cyberfin
sometimes referred to as a "Guarantor" and
collectively, the "Guarantors"), the Guarantors
represents and warrants the following:

Section 4.1    Organization and Qualification.
Cyberfin as a Guarantor hereunder is a corporation duly
organized, validly existing, and in good standing under
the  laws  of  Massachusetts,  and  has  the  requisite
corporate power to own its properties and to  carry  on
its business as now being conducted.

Section 4.2    Authorization, Enforcement, Compliance
with Other Instruments.
     (a)  Each Guarantor has the requisite power
     and authority (corporate and otherwise) to
     enter into and perform all their respective
     obligations under each of this Agreement, the
     Guaranty Agreement, the Pledge Agreement, and
     any related agreements (collectively, the
     "Pledge Agreements");
     (b)  The execution and delivery by the
     Guarantors of the Pledge Agreements and the
     consummation by each of them of the
     transactions contemplated thereby, including
     without limitation the pledge of the
     Collateral Shares and their deliver to a
     third party designated by Purchaser for
     holding, as part of Guarantor's obligations
     under the Stock Pledge Agreement, have been
     duly authorized by each of Kruy and
     Cyberfin's Board of Directors, and no further
     authorization, approval, or consent is
     required by Kruy or by Cyberfin, its Board of
     Directors, or its stockholders;
     (c)  the Pledge Agreements have been duly and
     validly executed and delivered by each of the
     Guarantors; and
     (d)  each of the Pledge Agreements
     constitutes the legal, valid, and binding
     obligation of each of the Guarantors
     enforceable against them in accordance with
     their respective terms, except as such
     enforceability may be limited by general
     principles of equity or applicable
     bankruptcy, insolvency, reorganization,
     moratorium, liquidation, or similar laws
     relating to, or affecting generally, the
     enforcement of creditors' rights and
     remedies.

SECTION 5.  representations, warranties, and covenants
of purchasers
Each Purchaser represents, warrants, and covenants to
the Company, with respect to such Purchaser only that:

Section 5.1    Investment Purpose.
Purchaser is acquiring the Securities for its own
account for investment only and not with a view
towards, or for resale in connection with, the public
sale or distribution thereof, except pursuant to sales
registered or exempted under the 1933 Act; provided
however, that by making the representations herein,
Purchaser does not agree to hold any Securities for any
minimum or other specific term and reserves the right
to dispose of the Securities at any time in accordance
with or pursuant to a registration statement or an
exemption under the 1933 Act.

Section 5.2    Accredited Investor Status.
Purchaser is an "accredited investor" as that term is
defined in Rule 501(a)(3) of Regulation D.

Section 5.3    Reliance on Exemptions.
Purchaser understands that the Securities are being
offered and sold to it in reliance on specific
exemptions from the registration requirements of United
States federal and state securities laws and that the
Company is relying in part upon the truth and accuracy
of, and Purchaser's compliance with, the
representations, warranties, agreements,
acknowledgments, and understandings of Purchaser set
forth herein in order to determine the availability of
such exemptions and the eligibility of Purchaser to
acquire such securities.

Section 5.4    Information.
Purchaser and its advisors, if any, have been furnished
with all materials relating to the business, finances,
and operations of the Company and materials relating to
the offer and sale of the Securities, which have been
requested by such Purchaser.  Purchaser and its
advisors, if any, have been afforded the opportunity to
ask questions of the Company.  Neither such inquiries
nor any other due diligence investigations conducted by
Purchaser or its advisors, if any, or its
representatives shall modify, amend, or affect such
Purchaser's right to rely on the Company's
representations and warranties contained in Section 3
hereof.  Purchaser understands that its investment in
the Securities involves a high degree of risk.
Purchaser has sought such accounting, legal, and tax
advice as it has considered necessary to make an
informed investment decision with respect to its
acquisition of the Securities.

Section 5.5    No Governmental Review.
Purchaser understands that no United States federal or
state agency or any other government or governmental
agency has passed on or made any recommendation or
endorsement of the Securities, or the fairness or
suitability of the investment in the Securities, nor
have such authorities passed upon or endorsed the
merits of the offering of the Securities.

Section 5.6    Transfer or Resale.
Purchaser understands that except as provided in the
Registration Rights Agreement:
     (a)  the Securities have not been and are not
     being registered under the 1933 Act or any
     state securities laws, and may not be offered
     for sale, sold, assigned, or transferred
     unless;

              (i)  subsequently registered thereunder;

              (ii) Purchaser shall have delivered to
         the Company an opinion of counsel, in a
         generally acceptable form, to the effect that
         such securities to be sold, assigned, or
         transferred may be sold, assigned, or
         transferred pursuant to an exemption from
         such registration; or

              (iii)     Purchaser provides the Company
         with reasonable assurance that such
         securities can be sold, assigned, or
         transferred pursuant to Rule 144 or
         promulgated under the 1933 Act (or a
         successor rule thereto);
     (b)  any sale of such securities made in
     reliance on Rule 144 promulgated under the
     1933 Act (or a successor rule thereto) ("Rule
     144") may be made only in accordance with the
     terms of Rule 144 and further, if Rule 144 is
     not applicable, any resale of such securities
     under circumstances in which the seller (or
     the person through whom the sale is made) may
     be deemed to be an underwriter (as that term
     is defined in the 1933 Act) may require
     compliance with some other exemption under
     the 1933 Act or the rules and regulations of
     the SEC thereunder; and
     (c)  neither the Company nor any other person
     is under any obligation to register such
     securities under the 1933 Act or any state
     securities laws or to comply with the terms
     and conditions of any exemption thereunder.

Section 5.7    Legends.
Purchaser understands that the certificates or other
instruments representing the Bridge Notes and, until
such time as the sale of the Conversion Shares have
been registered under the 1933 Act as contemplated by
the Registration Rights Agreement, the stock
certificates representing the Conversion Shares shall
bear a restrictive legend in substantially the
following form (and a stop transfer order may be placed
against transfer of such stock certificates):

     THE    SECURITIES   REPRESENTED    BY    THIS
     CERTIFICATE  HAVE  NOT BEEN REGISTERED  UNDER
     THE  SECURITIES ACT OF 1933, AS  AMENDED,  OR
     APPLICABLE   STATE  SECURITIES   LAWS.    THE
     SECURITIES  HAVE BEEN ACQUIRED FOR INVESTMENT
     AND  MAY  NOT  BE  OFFERED  FOR  SALE,  SOLD,
     TRANSFERRED, OR ASSIGNED IN THE ABSENCE OF AN
     EFFECTIVE  REGISTRATION  STATEMENT  FOR   THE
     SECURITIES UNDER THE SECURITIES ACT OF  1933,
     AS  AMENDED,  OR APPLICABLE STATE  SECURITIES
     LAWS,  OR  AN  OPINION  OF  COUNSEL,   IN   A
     GENERALLY  ACCEPTABLE FORM, THAT REGISTRATION
     IS  NOT REQUIRED UNDER SAID ACT OR APPLICABLE
     STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT
     TO RULE 144 UNDER SAID ACT.
The legend set forth above shall be removed and the
Company shall issue a certificate without such legend
to the holder of the Bridge Notes and the Conversion
Shares, upon which it is stamped, if, unless otherwise
required by state securities laws, (a) the sale of the
Conversion Shares is registered under the 1933 Act, (b)
in connection with a sale transaction, such holder
provides the Company with an opinion of counsel, in a
generally acceptable form, to the effect that a public
sale, assignment, or transfer of the Bridge Notes and
the Conversion Shares may be made without registration
under the 1933 Act, or (c) such holder provides the
Company with reasonable assurances that the Bridge
Notes and the Conversion Shares can be sold pursuant to
Rule 144 without any restriction as to the number of
securities acquired as of a particular date that can
then be immediately sold.

Section 5.8    Authorization Enforcement.
This Agreement has been duly and validly authorized,
executed, and delivered on behalf of Purchaser and is a
valid and binding agreement of Purchaser enforceable in
accordance with its terms, subject as to enforceability
to general principles of equity and to applicable
bankruptcy, insolvency, reorganization, moratorium,
liquidation, and other similar laws relating to, or
affecting generally, the enforcement of applicable
creditors' rights and remedies.

Section 5.9    Residence.
Purchaser is a resident of that country specified in
its address on the Schedule of Purchaser.

Section 5.10   No Scheme to Evade Registration.
Purchaser represents and warrants to the Company, as to
itself only, that the acquisition of the Securities is
not a transaction (or any element of a series of
transactions) that is part of a plan or scheme by the
Purchaser to evade the registration provisions of the
1933 Act and that
     (a)  such Purchaser is an "accredited
     investor" within the meaning of Rule 501
     under the Securities Act;
     (b)  such Purchaser has sufficient knowledge
     and experience to evaluate the risks and
     merits of its investment in the Company and
     it is able financially to bear the risks
     thereof;
     (c)  such Purchaser has had an opportunity to
     ask questions of and receive answers from and
     to discuss the Company's business,
     management, and financial affairs with the
     Company's management;
     (d)  the Securities are being acquired for
     its own account for the purpose of investment
     and not with a view to or for sale in
     connection with any distribution thereof;
     (e)  such Purchaser was not offered nor made
     aware of the Company's interest in issuing
     the Bridge Notes by any means of public
     advertisement or solicitation;
     (f)  in connection with such Purchaser's
     purchase of the Securities, it has been
     solely responsible for its own (i) due
     diligence investigation of the Company and
     (ii) investment decision, and has not engaged
     or relied upon any agent or "purchaser
     representative" to review or analyze the
     Company's business and affairs or advise
     Purchaser with respect to the merits of the
     investment;
     (g)  such Purchaser has full power and
     authority to execute, deliver, and perform
     this Agreement; and this Agreement
     constitutes the legal, valid, and binding
     obligation of such Purchaser, enforceable
     against it in accordance with their
     respective terms; and
     (h)  if such Purchaser proposes to sell the
     Securities pursuant to Rule 144A under the
     Securities Act, it will (A) take reasonable
     steps to obtain the information required by
     such Rule to establish a reasonable belief
     that the prospective purchaser is a
     "qualified institutional buyer" as such term
     is defined in Rule 144A and (B) advise the
     prospective purchaser that the Purchaser is
     relying on the exemption from the
     registration provisions of the Securities Act
     available pursuant to Rule 144A.

Section 5.11   Covenant Not to Trade.

     Each Purchaser for itself and on behalf of each
affiliate and associate of such Purchaser covenants and
agrees, not to purchase, sell, make any short sale of,
pledge, grant any option for the purchase or sale of or
otherwise trade any Common Stock prior to the
conversion of the Bridge Notes (other than a purchase
of Common Stock from the Company pursuant to the
exercise of the Repricing Warrant or the Warrant),
without the prior written consent of the Company.

SECTION 6.  CONDITIONS OF INITIAL CLOSING
The Purchaser's obligation to purchase and pay for the
Securities is subject to the satisfaction prior to or
at the Closing of the following conditions:

Section 6.1    Transaction Agreements.
The Company shall have delivered to Purchaser the
Transaction Agreements as provided in Section 1.5,
above, executed by all the parties thereto.

Section 6.2    Opinion of Counsel.
Purchaser shall have received from counsel for the
Company, an opinion in substantially the form of
Exhibit E, addressed to Purchaser, dated the Closing
Date.  To the extent that the opinion referred to in
the preceding sentence is rendered in reliance upon the
opinion of any other counsel, Purchaser shall have
received a copy of such opinion of such other counsel,
dated the Closing Date and addressed to Purchaser, or a
letter from such other counsel, dated the Closing Date
and addressed to Purchaser, authorizing Purchaser to
rely on such other counsel's opinion.

Section 6.3    Representations and Warranties; No
Default.
The representations and warranties of the Company
contained in this Agreement and those otherwise made in
writing by or on behalf of the Company in connection
with the transactions contemplated by this Agreement
shall be true in all material respects, except to the
extent of changes caused by the transactions
contemplated herein; provided however, that there shall
exist at the time of the Closing and after giving
effect to such transactions no Event of Default (as
defined in Section 10 of the Bridge Notes).

Section 6.4    Delivery of Schedules; Due Diligence.
Purchaser shall have received and in its discretion
shall be satisfied with the Disclosure Schedules and
the results of its due diligence investigations.

Section 6.5    Purchase and Loan Permitted by
Applicable Laws.
The purchase of, and payment for, all the Securities
evidenced by or attendant to the Bridge Notes shall not
violate any applicable domestic law or governmental
regulation (including, without limitation, Section 5 of
the Securities Act) and shall not subject Purchaser to
any tax, penalty, liability, or other onerous condition
under, or pursuant to, any applicable law or
governmental regulation or order.

Section 6.6    No Adverse Litigation.
There shall be no action, suit, investigation, or
proceeding, pending or, to the best of Purchaser's or
the Company's knowledge, threatened, against or
affecting Purchaser, the Company, any of Purchaser's or
the Company's properties or rights, or any of
Purchaser's or the Company's Affiliates, officers, or
directors, by or before any court, arbitrator, or
administrative or governmental body which (i) seeks to
restrain, enjoin, prevent the consummation of, or
otherwise affect the transactions contemplated by this
Agreement or (ii) questions the validity or legality of
any such transactions, or (iii) seeks to recover
damages or obtain other relief in connection with any
such transactions, and, to the best of Purchaser's and
the Company's knowledge, there shall be no valid basis
for any such action, proceeding, or investigation, and
Purchaser shall have received a certificate executed by
the chief executive officer of the Company, dated the
Closing Date, to such effect.

Section 6.7    Approvals and Consents.
The Company shall have duly received all
authorizations, waivers, consents, approvals, licenses,
franchises, permits, and certificates (collectively,
"Consents") by or of all federal, state, and local
governmental authorities and all material consents by
or of all other persons necessary or advisable for the
issuance of the Bridge Notes, all such consents shall
be in full force and effect at the time of Closing, and
Purchaser shall have received a certificate executed by
the chief executive officer of the Company, dated the
Closing Date, to such effect.

Section 6.8    No Material Adverse Change.

     Since November 12, 1999, there shall not have been
any material adverse change in the business, condition
(financial or other), assets, properties, operations,
or prospects of the Company, and Purchaser shall have
received a certificate executed by the chief executive
officer of the Company, dated the Closing Date, to such
effect.

Section 6.9    Proceedings.
All proceedings taken or to be taken in connection with
the transactions contemplated hereby, and all documents
incident thereto shall be reasonably satisfactory in
form and substance to Purchaser and Purchasers counsel,
and Purchaser and Purchasers counsel shall have
received all such counterpart originals or certified or
other copies of such documents as the Purchaser or
Purchasers' counsel may reasonably request.

Section 6.10   Clerk Certificate.
Purchaser shall have received a Clerk's Certificate
from the Clerk or an Assistant Clerk of the Company
dated the Closing Date and certifying: (A) that
attached thereto is a true and complete copy of the
Charter as then in effect, certified or bearing
evidence of filing by the Secretary of the Commonwealth
of Massachusetts, and (B) a certificate of said
Secretary of State, dated as of a recent date as to the
due incorporation and good standing of the Company, and
listing all documents of the Company on file with said
Secretary of State; (C) that attached thereto is a true
and complete copy of the Bylaws of the Company as in
effect on the date of such certification; (D) that
attached thereto is a true and complete copy of all
resolutions adopted by the Board of Directors or the
shareholders of the Company authorizing the execution,
delivery, and performance of Transaction Agreements and
the issuance, sale, and delivery of the Securities, and
that all such resolutions are in full force and effect
and are all the resolutions adopted in connection with
the foregoing agreements and the transactions
contemplated thereby; (E) that the Charter has not been
amended since the date of the last amendment referred
to in the certificate delivered pursuant to clause (A)
above; and (F) to the incumbency and specimen signature
of each officer of the Company executing all
Transaction Agreements and any certificate or
instrument furnished pursuant hereto, and a
certification by another officer of the Company as to
the incumbency and signature of the officer signing the
certificate.

Section 6.11   Transfer Agent Instructions.
The Transfer Agent Instructions, in form and substance
satisfactory to the Purchaser, shall have been
delivered to and acknowledged in writing by the
Company's transfer agent.

SECTION 7.  CONDITIONS TO SUBSEQUENT CLOSINGS

Section 7.1    Representations and Warranties; No
Default.
The representations and the warranties of the Company
contained in this Agreement and those otherwise made in
writing by or on behalf of the Company in connection
with the transactions contemplated by this Agreement
shall be true in all material respects, except to the
extent of changes caused by the transactions
contemplated herein; provided however, that there shall
exist no Event of Default under this Agreement or any
of the Bridge Notes at the time of the Subsequent
Closing.

Section 7.2    No Suspensions.
There shall be no suspensions of trading in or in
delisting (or pending delisting) of the Common Stock.

Section 7.3    Opinion of Counsel.
Purchaser shall have received from counsel for the
Company, an opinion in substantially the form of
Exhibit E, addressed to Purchaser, dated as of each
Additional Closing Date.  To the extent that the
opinion referred to in the preceding sentence is
rendered in reliance upon the opinion of any other
counsel, Purchaser shall have received a copy of such
opinion of such other counsel, dated the Additional
Closing Date and addressed to Purchaser, or a letter
from such other counsel, dated the Additional Closing
Date and addressed to Purchaser, authorizing Purchaser
to rely on such other counsel's opinion.

Section 7.4    Due Diligence.
Purchaser shall be satisfied with the results of
periodic due diligence investigations including without
limitation any supplemental Disclosure Schedules
delivered in connection with an Additional Closing and,
if so requested by the Representative, shall have
received a "comfort" letter from the Company's auditors
with respect to the financial statements filed by the
Company in its quarterly and annual securities filings.

Section 7.5    Shareholder Approval.
Company, if required, must obtain shareholder approval
on placement so as to address the 20% NASD rule.

Section 7.6    No Material Adverse Change.
Since date hereof, there shall not have been any
material adverse change in the business, condition
(financial or other), assets, properties, operations,
or prospects of the Company, and Purchaser.

SECTION 8.  AFFIRMATIVE COVENANTS
The Company covenants that from and after the date of
this Agreement through the Closing and thereafter so
long as any of the Bridge Notes remain outstanding:

Section 8.1    Financial Information.
     The Company shall furnish to Purchaser:
     (a)  within five (5) days after the filing
     thereof with the SEC, a copy of its Annual
     Reports on Form 10-K, its Quarterly Reports
     on Form 10-Q, any Current Reports on Form 8-
     K, and any registration statements or
     amendments filed pursuant to the 1933 Act;
     (b)  within one (1) day after release
     thereof, copies of all press releases issued
     by the Company or any of its subsidiaries;
     (c)  copies of the same notices and other
     information given to the stockholders of the
     Company generally, contemporaneously with the
     giving thereof to the stockholders;
     (d)  promptly upon any officer of the Company
     obtaining knowledge (i) of any condition or
     event which constitutes an Event of Default,
     (ii) that the holder of any Bridge Notes has
     given any notice or taken any other action
     with respect to a claimed Event of Default
     under this Agreement, (iii) of any condition
     or event which, in the opinion of management
     of the Company would have a material adverse
     effect on the business, condition (financial
     or other), assets, properties, operations, or
     prospects of the Company, other than
     conditions or events applicable to the
     economy as a whole, (iv) that any person has
     given any notice to the Company or taken any
     other action with respect to a claimed Event
     of Default, or (v) of the institution of any
     litigation involving claims against the
     Company, unless such litigation is defended
     by the insurance carrier without any
     reservation of rights and is reasonably
     expected to be fully covered by a
     creditworthy insurer, in an amount equal to
     or greater than $250,000 with respect to any
     single cause of action or of any adverse
     determination in any litigation involving a
     potential liability to the Company equal to
     or greater than $100,000 with respect to any
     single cause of action, a certificate
     executed by the chief executive officer of
     the Company specifying the nature and period
     of existence of any such condition or event,
     or specifying the notice given or action
     taken by such holder or person and the nature
     of such claimed Event of Default, event or
     condition, and what action the Company has
     taken, is taking, or proposes to take with
     respect thereto; and
     (e)  with reasonable promptness, such other
     information and data with respect to the
     Company as Purchaser may reasonably request.

Section 8.2    Form D.
The Company agrees to file a Form D with respect to the
Securities as required under Regulation D and to
provide a copy thereof to each Purchaser promptly after
such filing.  The Company shall, on or before the
Closing Date, take such action as the Company shall
reasonably determine is necessary to qualify the
Securities for, or obtain exemption for the Securities
for, sale to the Purchaser at the Closing pursuant to
this Agreement under applicable securities or "Blue
Sky" laws of the states of the United States, and shall
provide evidence of any such action so taken to the
Purchaser on or prior to the Closing Date.

Section 8.3    Reporting Status.
Until the earlier of (a) the date as of which the
Investors (as that term is defined in the Registration
Rights Agreement) may sell all of the Conversion Shares
without restriction pursuant to Rule l44(k) promulgated
under the 1933 Act (or successor thereto), or (b) the
date on which (i) the Investors shall have sold all the
Conversion Shares and (ii) none of the Bridge Notes is
outstanding (the "Registration Period"), the Company
shall file all reports required to be filed with the
SEC pursuant to the 1934 Act, and the Company shall not
terminate its status as an issuer required to file
reports under the 1934 Act even if the 1934 Act or the
rules and regulations thereunder would otherwise permit
such termination.

Section 8.4    Inspection of Property.
The Company will permit any Person designated by any
Purchaser in writing, at Purchaser's expense, to visit
and inspect any of the properties of the Company, to
examine the books and financial records of the Company
and make copies thereof or extracts therefrom and to
discuss its affairs, finances, and accounts with its
officers and its independent public accountants, all at
reasonable times and upon reasonable prior notice to
the Company.

Section 8.5    Maintenance of Properties; Insurance.
The Company will maintain or cause to be maintained in
good repair, working order, and condition all
properties used or useful in the business of the
Company and from time to time will make or cause to be
made all appropriate repairs, renewals, and
replacements thereof.  The Company will maintain or
cause to be maintained, with financially sound and
reputable insurers (or, as to workers' compensation or
similar insurance, in an insurance fund or by self-
insurance authorized by the laws of the jurisdiction in
question), insurance with respect to their respective
properties and businesses against loss or damage of the
kinds customarily insured against by corporations of
established reputation engaged in the same or similar
businesses and similarly situated, of such type and in
such amounts as are customarily carried under similar
circumstances by such other corporations and as are in
good faith believed by the Company to be sufficient to
prevent the Company from becoming a co-insurer within
the terms of the policies in question.

Section 8.6    Reserved.

Section 8.7    Expenses.
The Company and Purchasers shall pay all costs and
expenses incurred by such party in connection with the
negotiation, investigation, preparation, execution, and
delivery of this Agreement, the Bridge Notes, the
Escrow Agreement, the Registration Rights Agreement,
and other documents executed in connection with the
issuance of the Bridge Notes.  The costs and expenses
of Sovereign Capital, LLC including the fees and
expenses of Balboni Law Group, LLC (not to exceed
$20,000 in fees and expenses for both Closings) shall
be paid for by the Company at each Closing, as
indicated on each release notice executed by the
Company and submitted to the Escrow Agent. The fee
limits of counsel to Sovereign Capital Advisors, LLC
cited in this Section 8.7 are subject to the assumption
that two Closings are needed to complete the Offering,
and further subject in all instances to such counsel
providing all transaction documents, agreements,
certificates, and the like necessary for the
transactions contemplated hereunder, and receiving a
reasonable level of comments thereto. However, should
such counsel prepare such documents, agreements, and
certificates for any Additional Closing and
subsequently receive substantial additional comments to
such documents, agreements, and certificates (for
example, as a result of changes requested by or
comments of the Company to any part or structure of the
transactions contemplated hereunder), then such hourly
limits for any given Additional Closing shall not apply
and such counsel shall bill and the Company agrees to
pay for all such additional work at such counsel's
normal hourly rates then in effect.

Section 8.8    Authorized Shares of Common Stock,
Reservation of Shares.
The Company shall at all times, so long as any of the
Bridge Notes are outstanding, reserve and keep
available out of its authorized and unissued Common
Stock, solely for the purpose of effecting the
conversion of the Bridge Notes, such number of shares
of Common Stock equal to or greater than 150% of the
number of Conversion Shares issuable upon conversion of
the Bridge Notes which are then outstanding or which
could be issued at any time under this Agreement.

Section 8.9    Corporate Existence, Etc.
The Company will at all times preserve and keep in full
force and effect its corporate existence, and rights,
licenses, and franchises material to its business, and
will qualify to do business as a foreign corporation in
each jurisdiction where the failure to so qualify would
have a material adverse effect on the business,
condition (financial or other), assets, properties, or
operations of the Company, taken as a whole.

Section 8.10   Transfer Agents.
The Company covenants and agrees that, in the event
that the Company's agency relationship with the
transfer agent should be terminated for any reason
prior to a date which is two (2) years after the
Closing Date, the Company shall immediately appoint a
new transfer agent and shall require that the transfer
agent execute and agree to be bound by the terms of the
Irrevocable Instructions to Transfer Agent.

Section 8.11   Shareholder Approval; Proxy.
The Company covenants to submit to its shareholders a
proposal for ratification of the issuance of the Bridge
Notes and the Conversion Shares, if and as required by
the rules of the National Association of Securities
Dealers, Inc. (the "NASD") applicable to the
transaction. All officers and directors will, upon
request of Purchaser, execute a proxy authorizing
Purchaser or any designee of Purchaser to vote all
shares of Common Stock, the voting of which is
controlled by such officer or director, at any meeting
(or any adjournment thereof) at which Shareholder
action is proposed to ratify the issuance of the Bridge
Notes and the Conversion Shares.

Section 8.12   Transfer Agent Instructions.
The Company shall issue Transfer Agent Instructions to
its transfer agent to issue certificates, registered in
the name of the Purchaser or its respective nominee(s),
for the Conversion Shares, the Repricing Shares, and
the Warrant Shares in such amounts as specified from
time to time by the Purchaser to the Company upon
conversion of the Bridge Notes, except as provided in
Section 8.8 herein.  Prior to registration of the
Conversion Shares under the 1933 Act, all such
certificates shall bear the restrictive legend
specified in Section 5.7 of this Agreement.  The
Company warrants that no instruction other than the
Transfer Agent Instructions referred to in this Section
8.12, and stop transfer instructions to give effect to
Section 5.7 hereof (in the case of the Conversion
Shares, prior to registration of such shares under the
1933 Act) will be given by the Company to its transfer
agent and that the Bridge Notes and the Conversion
Shares shall otherwise be freely transferable on the
books and records of the Company as and to the extent
provided in this Agreement and the Registration Rights
Agreement.  Nothing in this Section 8.12 shall affect
in any way the Purchaser's obligations and agreement to
comply with all applicable securities laws upon resale
of the Bridge Notes or Conversion Shares.  If the
Purchaser provides the Company with an opinion of
counsel, reasonably satisfactory in form, and substance
to the Company, that registration of a resale by the
Purchaser of any of the Bridge Notes or Conversion
Shares is not required under the 1933 Act, the Company
shall permit the transfer, and, in the case of the
Conversion Shares, promptly instruct its transfer agent
to issue one or more certificates in such name and in
such denominations as specified by the Purchaser.  The
Company acknowledges that a breach by it of its
obligations hereunder will cause irreparable harm to
the Purchaser by vitiating the intent and purpose of
the transaction contemplated hereby.  Accordingly, the
Company acknowledges that the remedy at law for a
breach of its obligations under this Section 8.12 will
be inadequate and agrees, in the event of a breach or
threatened breach by the Company of the provisions of
this Section 8.12, that the Purchaser shall be
entitled, in addition to all other available remedies,
to an injunction restraining any breach and requiring
immediate issuance and transfer, without the necessity
of showing economic loss and without any bond or other
security being required.

Section 8.13   Payment of Taxes.
The Company will pay all taxes, assessments, and other
governmental charges imposed upon it or any of its
properties or assets or in respect of any of its
franchises, business, income, or properties before any
penalty or significant interest accrues thereon, and
all claims (including, without limitation, claims for
labor, services, materials, and supplies) for sums
which have become due and payable and which by law have
or may become a lien upon any of its properties or
assets, provided that no such charge or claim need be
paid if such claim is (i) being contested in good faith
by appropriate proceedings promptly instituted and
diligently conducted, and (ii) the amount of such claim
is accrued on the financial statements of the Company
or other appropriate provision is made as shall be
required by generally accepted accounting principles.

Section 8.14   Compliance with Laws, Etc.
The Company will comply with the requirements of all
applicable laws, rules, regulations, and orders of any
court or other governmental authority (including,
without limitation, those related to environmental or
ERISA compliance), noncompliance with which could
materially adversely affect the business, condition
(financial or other), assets, property, operations, or
prospects of the Company.

Section 8.15   Use of Proceeds.
The Company will use the proceeds from the sale and
issuance of the Bridge Notes as follows: provide the
Company with operating capital, repayment of certain
limited existing indebtedness of the Company, and
capital expenditures.

Section 8.16   Registration Statement.
The Company shall (a) file a Registration Statement,
covering the resale of shares of Common Stock received
upon conversion of the Bridge Notes, the Repricing
Warrants, and the Warrants to permit the holder(s)
thereof to resell from and after the Registration
Deadline (as such term is defined therein) in
accordance with the Registration Rights Agreement, (b)
use its best efforts to have the Registration Statement
declared effective in accordance with the Registration
Rights Agreement, and (c) keep such Registration
Statement current and effective for a period 12 months
from the effective date of such Registration Statement
in accordance with the Registration Rights Agreement.

Section 8.17   Listings.

     The Company shall promptly secure the listing of
the Conversion Shares, the Repricing Shares, and the
Warrant Shares upon each national securities exchange
or automated quotation system, if any, upon which
shares of Common Stock are then listed (subject to
official notice of issuance) and shall maintain, so
long as any other shares of Common Stock shall be so
listed, such listings of all Conversion Shares, the
Repricing Shares, and the Warrant Shares from time to
time issuable under the terms of the Bridge Notes, the
Repricing Warrants, the Warrants, and the Registration
Rights Agreement. The Company shall maintain the Common
Stock's authorization for quotation in the over-the-
counter market. The Company shall promptly provide to
Purchaser copies of any notices it receives regarding
the continued eligibility of the Common Stock for
trading in the over-the-counter market.

Section 8.18   Indemnification.
In consideration of the Purchaser's execution and
delivery of this Agreement and acquiring the Securities
hereunder and in addition to all of the Company's other
obligations under this Agreement, the Company shall
defend, protect, indemnify, and hold harmless each
Purchaser and each other holder of the Securities and
each officer, director, employee, and agent of each
Purchaser (including, without limitation, those
retained in connection with the transactions
contemplated by this Agreement) (collectively, the
"Indemnitees") from and against any and all actions,
causes of action, suits, claims, losses, costs,
penalties, fees, liabilities, and damages, and expenses
in connection therewith (irrespective of whether any
such Indemnitee is a party to the action for which
indemnification hereunder is sought), and including
reasonable attorneys' fees and disbursements (the
"Indemnified Liabilities"), incurred by the Indemnitees
or any of them as a result of, or arising out of, or
relating to (a) any misrepresentation or breach of any
representation or warranty made by the Company in any
Transaction Agreement or any other certificate,
instrument, or document contemplated hereby or thereby,
(b) any breach of any covenant, agreement, or
obligation of the Company contained in the Transaction
Agreements, or any other certificate, instrument or
document contemplated hereby or thereby, or (c) any
cause of action, suit, or claim brought or made against
such Indemnitee and arising out of or resulting from
the execution, delivery, performance, or enforcement of
this Agreement or any other instrument, document, or
agreement executed pursuant hereto by any of the
Indemnitees, any transaction financed or to be financed
in whole or in part, directly or indirectly, with the
proceeds of the issuance of the Bridge Notes, or the
status of the Purchaser  or holder of the Bridge Notes
or the Conversion Shares, as an investor in the
Company.  To the extent that the foregoing undertaking
by the Company may be unenforceable for any reason, the
Company shall make the maximum contribution to the
payment and satisfaction of each of the Indemnified
Liabilities which is permissible under applicable law.

SECTION 9. NEGATIVE COVENANTS
     The provisions of this Section 9 shall remain in
     effect so long as any of the Bridge Notes shall
     remain outstanding.
     Section 9.1    Definition of Debt.  For purposes
     of this Agreement, the capitalized term "Debt" of
     any Person shall mean:
     (a)  all indebtedness of such Person for
     borrowed money, including without limitation
     obligations evidenced by bonds, debentures,
     Bridge Notes, or other similar instruments;
     (b)  all indebtedness of others for borrowed
     money guaranteed in any manner by such
     Person, or in effect guaranteed by such
     Person through an agreement to purchase,
     contingent or otherwise;
     (c)  all accounts payable which, to the
     knowledge of such Person, have remained
     unpaid for a period of 90 days after the same
     become due and payable in accordance with
     their respective terms taking into account
     any grace period relating to the due date
     expressly set forth in the applicable invoice
     with respect to the payment of such accounts
     payable, except for the trade payables
     previously disclosed by the Company that have
     remained unpaid for more than ninety days as
     of the date of this Agreement that have been
     disclosed in the Company's SEC Documents;
     (d)  all indebtedness secured by any
     mortgage, lien, pledge, charge, security
     interest or other encumbrance upon or in
     property owned by such Person, even though
     such Person has not assumed or become liable
     for the payment of such indebtedness;
     (e)  all indebtedness created or arising
     under any conditional sale agreement or lease
     in the nature thereof (including obligations
     as lessee under leases which shall have been
     or should be, in accordance with generally
     accepted accounting principles, recorded as
     capitalized leases) (but excluding operating
     leases) or other title retention agreement
     with respect to property acquired by such
     Person, even though the rights and remedies
     of the seller or lender under such agreement
     in the event of default are limited to
     repossession of such property;
     (f)  all bankers' acceptances and letters of
     credit; and
     (g)  liabilities in respect of unfunded
     vested benefits under Plans covered by Title
     IV of ERISA.

Section 9.2    Restrictions on Debt.
The Company will not create, assume, or incur or become
or at any time be liable in respect of, any Debt
without the consent of the Purchasers, except:
     (a)  the Bridge Notes issued pursuant to this
     Agreement;
     (b)  Debt outstanding on the date hereof to
     the extent reflected on the most recent
     balance sheet of the Company or incurred in
     the ordinary course of business thereafter;
     (c)  Debt incurred pursuant to the Company's
     existing line of credit facility with BA
     Associates originated November 9, 1998, under
     which the Company may borrow from time to
     time up a maximum of $650,000, as referenced
     in Section 3.3(b) of the Disclosure Schedule;
     (d)  Debt incurred in permitted real estate
     investments; and
     (e)  purchase money security interests not to
     exceed $250,000 per year.
Notwithstanding the foregoing provisions of this
Section 9.2, the Company will not create, assume, or
incur, or become or at any time be liable in respect
of, any Debt for money borrowed, advances made, or
goods purchased, if the Purchaser, the Person making
such advances, or the vendor of such goods (or any
Person who guarantees or becomes surety for all or any
part of such Debt or acquires any right or incurs any
obligation to become, either immediately or upon the
occurrence of some future contingency, the owner of all
or any part thereof) shall have any right, by reason of
any statute or otherwise, to have any claim in respect
of such Debt first satisfied out of the general assets
of the Company in priority to the claims of its general
creditors.

Section 9.3    Restrictions on Dividends.
The Company will not (a) pay any dividends, in cash or
otherwise, on, (b) make any distributions to holders
of, or (c) purchase, redeem, or otherwise acquire any
of its outstanding Common Stock or Preferred Stock or
set apart assets for a sinking or other analogous fund
for the purchase, redemption, retirement, or other
acquisition of, any shares of its Common Stock or
Preferred Stock; provided however, that the Company
may, so long as at the time of and after giving effect
thereof no Event of Default has occurred and is
continuing:  (i) pay dividends on its outstanding
Preferred Stock in accordance with the Charter;
(ii) with prior written approval of each Purchaser,
repurchase shares of its Common Stock issued or to be
issued by the Company upon exercise of stock options
granted to employees and directors of the Company
pursuant to the terms of plans adopted by the Board of
Directors of the Company; and (iii) pay cash in lieu of
fractional shares of its Common Stock on the exercise
of outstanding warrants to purchase its Common Stock,
pursuant to the terms of such warrants.

Section 9.4    Restrictions on Transactions with
Affiliates.
The Company will not make any loans or advances to any
of its officers, directors, shareholders, or
Affiliates, other than expense advances made by the
Company to its officers and employees in the ordinary
course of business.  The Company may increase the
salaries executive officer or the remuneration of any
director up to an aggregate maximum in all such
instances of $100,000, and otherwise will not increase
the salary of any executive officer or the remuneration
of any director.

Section 9.5    Restrictions on Investments.
Other than as permitted by this Agreement, the Company
will not purchase or acquire or invest in, or agree to
purchase or acquire or invest in the business,
property, or assets of, or any securities of, any other
company or business, provided however, that the Company
may invest its Excess Cash as defined below in:
     (a)  securities issued or directly and fully
     guaranteed or insured by the United States
     government or any agency thereof having
     maturities of not more than one year from the
     date of acquisition;
     (b)  certificates of deposit or eurodollar
     certificates of deposit, having maturities of
     not more than one hundred eighty days from
     the date of acquisition, or one year from the
     date of acquisition in the case of
     certificates of deposit or eurodollar
     certificates of deposit being used to secure
     the Company's reimbursement obligations under
     letters of credit (provided that nothing
     contained herein shall be construed to permit
     letters of credit not otherwise permitted
     under this Agreement);
     (c)  commercial paper of any Person that is
     not a subsidiary or an Affiliate of the
     Company, maturing within one hundred eighty
     days after the date of acquisition;
     (d)  bank loan participations; and
     (e)  money market instruments having
     maturities of not more than one hundred
     eighty days from the date of acquisition, or
     one year from the date of acquisition in the
     case of money market instruments being used
     to secure the Company's reimbursement
     obligations under letters of credit (provided
     that nothing contained herein shall be
     construed to permit letters of credit not
     otherwise permitted under this Agreement);

in all cases of such credit quality as a prudent
business person would invest in.  As used in this
Section, "Excess Cash" shall mean that portion of the
proceeds of the Bridge Notes which has not been
invested as described in Section 8.15 hereof.

Section 9.6    Restrictions on Sale and Lease-Back
Transactions.
The Company will not sell or transfer any of its
properties to anyone with the intention of taking back
a lease of the same property or leasing other property
for substantially the same use as the property being
sold or transferred; provided however, that (a) the
Company may continue and extend its existing leasing
arrangements and may lease, under operating leases, any
fixtures, equipment, and real estate that do not
constitute Pledged Assets in the ordinary course of
business of the Company, and (b) the Company may
otherwise make real estate investments but only with
the consent of the Purchasers as provided for herein.

Section 9.7    Restrictions on Sales of Assets.
The Company will not sell, transfer, or dispose of any
property except for sales of obsolete equipment having
a book value at the time of sale of not more than
$100,000 in the aggregate in any fiscal year.

Section 9.8    Restrictions on Subsidiaries.
The Company will not, without the written consent of
Purchaser to organize, or transfer any assets to, any
Subsidiaries, provided that, if consent of the
Purchasers is obtained and any Subsidiaries are
organized, or assets transferred, in compliance with
this Section 9.8, the Company will not permit such
Subsidiaries to enter into any transaction or agreement
which would violate any of the provisions of this
Section 9 if such provisions were applicable to such
Subsidiary.

Section 9.9    Change in Business; Operations.
The Company will not cause or effect any change in or
addition to the primary business of the Company that
has not been approved by Purchaser, such that more than
10% of the gross revenues of the Company are derived
from a business other than the business in which the
Company was engaged on the date hereof as reflected in
the applicable last SEC Document filed prior to the
First Closing ("Change in Business"), except any such
changes approved in advance in writing by the
Representative. The business of the Company and its
subsidiaries shall not be conducted in violation of any
law, ordinance, or regulation of any governmental
entity.

Section 9.10   Exceptions With Consent of Purchasers.
The Company may seek an exception to any prohibited
action under this Section by first, giving written
notice to all Purchasers of Bridge Notes under this
Agreement, along with copies of all documentation
requested by any Purchaser relating to such requested
exception, and second, in the sole discretion of
Purchasers, satisfactorily responding to any Purchaser
inquiries about the requested action. The Company may
undertake any such requested action otherwise
prohibited by this Section 9 only after receiving the
advance written consent of Purchasers representing not
less than two-thirds (2/3) of all amounts due under
Bridge Notes issued hereunder and then outstanding.

SECTION 10.    Miscellaneous.

Section 10.1   Counterparts.
This Agreement may be executed in two or more identical
counterparts, all of which shall be considered one and
the same agreement and shall become effective when
counterparts have been signed by each party and
delivered to the other party.  In the event any
signature page is delivered by facsimile transmission,
the party using such means of delivery shall cause four
(4) additional original executed signature pages to be
physically delivered to the other party within five (5)
days of the execution and delivery hereof.

Section 10.2   Headings.
The headings of this Agreement are for convenience of
reference and shall not form part of, or affect the
interpretation of, this Agreement.

Section 10.3   Severability.
If any provision of this Agreement shall be invalid or
unenforceable in any jurisdiction, such invalidity or
unenforceability shall not affect the validity or
enforceability of the remainder of this Agreement in
that jurisdiction or the validity or enforceability of
any provision of this Agreement in any other
jurisdiction.

Section 10.4   Entire Agreement. Amendments.
This Agreement supersedes all other prior oral or
written agreements between the Purchaser, the Company,
their affiliates and persons acting on their behalf
with respect to the matters discussed herein, and this
Agreement and the instruments referenced herein contain
the entire understanding of the parties with respect to
the matters covered herein and therein and, except as
specifically set forth herein or therein, neither the
Company nor any Purchaser makes any representation,
warranty, covenant, or undertaking with respect to such
matters.  No provision of this Agreement may be waived
or amended other than by an instrument in writing
signed by the party to be charged with enforcement.

Section 10.5   Notices.
Any notices, consents, waivers, or other communications
required or permitted to be given under the terms of
this Agreement must be in writing and will be deemed to
have been delivered (a) upon receipt, when delivered
personally, (b) upon receipt, when sent by facsimile,
provided a copy is mailed by U.S. certified mail,
return receipt requested, (c) three (3) days after
being sent by U.S. certified mail, return receipt
requested, or (d) one (1) day after deposit with a
nationally recognized overnight delivery service, in
each case properly addressed to the party to receive
the same.  The addresses and facsimile numbers for such
communications shall be:
     If to the Company:
                         Cambex Corporation
                         360 Second Avenue
                         Waltham, Massachusetts 02451
                         Attention: Peter Kruy,
                         Executive Vice President
                         Tel: (781) 890-6000
                         Fax: (781) 890-2899

              With a copy to:
                         Ropes & Gray
                         One International Place
                         Boston, Massachusetts  02110
                         Attention: John E. Beard
                         Tel: (617) 951-7000
                         Fax: (617) 951-7050
If to any Purchaser, to its address and facsimile
number on the signature page of such Purchaser hereto,
with copies to such Purchaser's counsel as set forth on
the signature page of such Purchaser hereto.  Each
party shall provide five- (5) days prior written notice
to the other party of any change in address or
facsimile number.

Section 10.6   Interest.
In no event shall the amount of interest due or payable
hereunder or under the Bridge Notes exceed the maximum
rate of interest allowed by applicable law, and if any
such payment is inadvertently made by the Company or is
inadvertently received by any holder of Bridge Notes,
then such excess sum shall be credited as a payment of
principal, unless the applicable holder of a Bridge
Notes shall notify the Company in writing that it
elects to have such excess sum returned forthwith.  It
is the express intent hereof that the Company not pay
and the holder of the Bridge Notes not receive,
directly or indirectly in any manner whatsoever,
interest in excess of that which may legally be paid by
the Company under applicable law.

Section 10.7   Successors and Assigns.
This Agreement shall be binding upon and inure to the
benefit of the parties and their respective successors
and assigns.  The Company shall not assign this
Agreement or any rights or obligations hereunder
without the prior written consent of the Purchasers.
Any Purchaser may assign its rights hereunder without
the consent of the Company, provided however, that any
such assignment shall not release such Purchaser from
its obligations hereunder unless such obligations are
assumed by such assignee and the Company has consented
to such assignment and assumption.

Section 10.8   No Third Party Beneficiaries.
This Agreement is intended for the benefit of the
parties hereto and their respective permitted
successors and assigns, and is not for the benefit of,
nor may any provision hereof be enforced by, any other
person.

Section 10.9   Publicity.
The Company and Purchasers shall have the right to
approve, before issuance, any press releases or any
other public statements with respect to the
transactions contemplated hereby; provided however,
that the Company shall be entitled, without the prior
approval of Purchasers, to make any press release or
other public disclosure with respect to such
transactions as is required by applicable law and
regulations (although the Purchaser shall be consulted
by the Company in connection with any such press
release or other public disclosure prior to its release
and shall be provided with a copy thereof).

Section 10.10  Further Assurances.
Each party shall do and perform, or cause to be done
and performed, all such further acts and things, and
shall execute and deliver all such other agreements,
certificates, instruments, and documents, as the other
party may reasonably request in order to carry out the
intent and accomplish the purposes of this Agreement
and the consummation of the transactions contemplated
hereby.

Section 10.11  No Strict Construction.
The language used in this Agreement will be deemed to
be the language chosen by the parties to express their
mutual intent, and no rules of strict construction will
be applied against any party.

Section 10.12  Governing Law.
This Agreement shall be governed by and construed in
accordance with the laws of the Commonwealth of
Massachusetts, irrespective of the choice of law
provisions thereof.  The parties agree that any action
brought by one party against the other shall be in any
appropriate state court or any federal Court located in
the County where the party against whom the action is
brought is principally located, and both parties agree
that such courts shall have exclusive jurisdiction of
such case or controversy arising under or in connection
with this Agreement and shall be a proper forum in
which to adjudicate such case or controversy.  The
parties consent to the jurisdiction of such courts.

IN WITNESS WHEREOF, Purchasers and the Company have
caused this Series 1 Bridge Note Purchase Agreement to
be duly executed as of the date first written above.

          [Signatures on the following page]

                COMPANY SIGNATURE PAGE
                          TO
        SERIES 1 BRIDGE NOTE PURCHASE AGREEMENT

                                   COMPANY

                                   CAMBEX CORPORATION

By: /s/ Peter Kruy

Peter Kruy, Executive Vice President
               GUARANTORS SIGNATURE PAGE
                          TO
        SERIES 1 BRIDGE NOTE PURCHASE AGREEMENT

                                   GUARANTORS

                                   CYBERFIN CORP.

                                   By: /s/ Peter Kruy
                                     Peter Kruy,
                                   President

                                   /s/ Joseph Kruy
                                   Joseph Kruy

           PURCHASER SIGNATURE PAGE (ENTITY)
                          TO
        SERIES 1 BRIDGE NOTE PURCHASE AGREEMENT

                                   PURCHASER

                                   Purchaser Name:
                                   SovCap Equity
                                   Partners, Ltd.

                                   By: /s/ Barry W.
                                   Herman

                                   Name: Barry W.Herman

                                   Title: Director

Purchaser Name      SovCap Equity Partners, Ltd.
Address and
Facsimile Number    Cumberland House

                    #27 Cumberland Street

                    P.O. Box CB - 13016

                    Nassau, New Providence

                    242-356-0037

Principal Amount
of Bridge Notes     $1,500,000.00 - Cambex Corporation
Purchased

Purchaser's Legal   Balboni Law Group, L.L.C.
Counsel
Address and         3475 Lenox Road, Suite 990
Facsimile Number
                    Atlanta, GA 30326

                    404-812-3101
           PURCHASER SIGNATURE PAGE (ENTITY)
                          TO
        SERIES 1 BRIDGE NOTE PURCHASE AGREEMENT

                                   PURCHASER

                                   Purchaser Name:
                                   Correllus
                                   International Ltd.

                                   By: /s/ Jan Telander

                                   Name: Jan Telander

                                   Title: Director

Purchaser Name      Correllus International Ltd.
Address and
Facsimile Number    c/o EIG Corporate Finance Services

                    Edificio Marina Marbella, 6B

                    Avenida Sever Olhoa 28, 29600 Marbella,
                    Spain

                    Fax: +34-952-858-068

Principal Amount
of Bridge Notes     US$ 250,000.00
Purchased

Purchaser's Legal   Per Ronnstrom
Counsel
Address and         Box 7315
Facsimile Number
                    SE-10390 Stockholm, Sweden

                    Fax: +46-8-796-8223
           PURCHASER SIGNATURE PAGE (ENTITY)
                          TO
        SERIES 1 BRIDGE NOTE PURCHASE AGREEMENT

                                   PURCHASER

                                   Purchaser Name: Arab
                                   Commerce Bank Ltd.

                                   By: /s/ A. De Nazareth

                                   Name: A. De Nazareth

                                   Title: Co. Secretary

Purchaser Name      Arab Commerce Bank Ltd.
Address and
Facsimile Number    P.O. Box 309

                    Grand Cayman

                    Cayman Islands

                    0171 437 2413 (London)

Principal Amount
of Bridge Notes     US$ 150,000.00
Purchased

Purchaser's Legal
Counsel
Address and
Facsimile Number

           PURCHASER SIGNATURE PAGE (ENTITY)
                          TO
        SERIES 1 BRIDGE NOTE PURCHASE AGREEMENT

                                   PURCHASER

                                   Purchaser Name:
                                   SovCap Equity
                                   Partners, Ltd.

                                   By: /s/ Barry W. Herman

                                   Name: Barry W.Herman

                                   Title: President

Purchaser Name      SovCap Equity Partners, Ltd.
Address and
Facsimile Number    Cumberland House

                    #27 Cumberland Street

                    P.O. Box N-10818

                    Nassau, New Providence, The Bahamas

                    242-356-0037

Principal Amount
of Bridge Notes     $100,000.00
Purchased

Purchaser's Legal
Counsel
Address and
Facsimile Number

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00011-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00011-of-00352.parquet"}]]